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Abstract 
Capillary networks within skeletal muscle and adipose tissue have a critical role in the 
delivery of energy sources and the maintenance of proper tissue function. A reduction in capillary 
density is correlated with impairments in whole-body metabolic functions, as occurs in obesity. 
The susceptibility to develop obesity-related metabolic disturbances differs between males and 
females. However, studies investigating these sex-related differences have overlooked the 
potential contribution of capillary content. The goal of this study was to determine whether there 
are sex-related differences in skeletal muscle and adipose tissue microvascular content and to relate 
these to the development of metabolic dysregulations in mice fed either a normal chow (NC) diet 
or a high-fat (HF) diet.  
Following 16 weeks of HF diet, whole-body, as well as skeletal muscle and adipose tissue, 
response to insulin was maintained in HF female but not HF male mice. In the muscle, this was 
accompanied by higher levels of endothelial cell marker PECAM-1 in HF females. However, no 
significant difference in capillary and arteriole distribution was established. Microvascular content 
in the visceral adipose was reduced in HF males, but maintained in HF females which also had a 
healthier adipokine profile. This was further supported by higher levels of PECAM-1 and pro-
angiogenic factor VEGF-A in HF females vs. HF male mice.  
These results provide evidence that sex-related differences exist in the angiogenic 
responses to a HF diet. The maintained capillary content within visceral adipose of HF female 
mice may in turn contribute to the better metabolic profile in HF females. This highlights the 
possible associations that may exist between metabolic and vascular parameters and provides the 
opportunity to explore sex-dependent signaling pathways that regulate capillary content within the 
context of diet-induced obesity. 
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Chapter 1: Literature Review 
1.1 Microvasculature 
The microvasculature, comprised of capillaries, arterioles and venules, is the primary site 
for the delivery and exchange of nutrients, gases and removal of metabolic waste. Therefore, 
microvessel structure and function is critical for maintenance of metabolic health and function of 
the surrounding tissues. Capillaries are the smallest (5-8µm in dimeter) and most abundant unit of 
the vasculature (Wiedman 1963). Capillaries are lined by a single layer of endothelial cells and 
surrounded by the extracellular matrix. Endothelial cells lining capillaries are estimated to be 0.5-
1 µm in thickness and can be distinguished by cell surface antigens such as platelet endothelial 
cell adhesion molecule-1 (PECAM-1) (Pries et al. 2000). The structural composition of capillaries 
enables efficient trans-capillary diffusion (Bruns and Palade 1968; Krogh 1919). The capacity of 
capillaries for nutrient and gas exchange is dependent on blood flow and total delivery of 
molecules. This is controlled by upstream tissue arterioles which in addition to the endothelium, 
are lined by layers of smooth muscle cells (SMCs) (Ellsworth and Pittman 1990; Segal 2005). The 
Presence of SMCs gives arterioles the ability to constrict or dilate and alter vessel lumen size. This 
permits the control of blood flow and in turn influences capillary recruitment and perfusion of the 
target tissue. Capillary number is not static and it can change depending on the requirements of 
the surrounding tissue and in response to molecular and mechanical stimuli (Haas and Nwadozi 
2015; Olfert et al. 2016). In adults, adaptations in capillary number can be in the form of capillary 
rarefaction, stabilization, or growth through the process of angiogenesis.  
 
 
 
 2 
1.1.1 Angiogenesis 
Angiogenesis is the formation of new capillaries from a pre-existing capillary network 
(Flier et al. 1995). In vivo, this process was first explored by Clark & Clark, in transparent tails of 
larva and by insertion of a transparent chamber within the ear of rabbits, where growth of capillary 
networks was observed by microscopy (1939). Angiogenesis occurs in embryonic development 
and in adults in the female reproductive system, during wound healing, tumour growth, and in 
response to exercise (Gustafsson 2011). Physiological angiogenesis occurs to maintain metabolic 
homeostasis within growing tissues (e.g. muscle) to ensure appropriate delivery of oxygen and 
nutrients (Haas 2002). An increase in capillary number increases surface area for exchange and 
reduces the diffusion distance of molecules in times of increased metabolic demand (Krogh 1919).  
 
1.1.2 Abluminal Sprouting and Intussusceptive Angiogenesis 
There are two forms of angiogenesis termed abluminal sprouting and intussusceptive, both 
of which result in the formation of endothelium-lined capillaries. Abluminal sprouting 
angiogenesis requires lateral growth of endothelial cells from the abluminal side of one capillary 
to connect to another existing capillary (Haas 2002). This type of angiogenesis requires activation 
of endothelial cells and loosening of endothelial cell junctions by extracellular stimuli. Once 
activated, matrix metalloproteinase (MMP) enzymes degrade the extracellular matrix (ECM) and 
pave the way for the newly proliferated endothelial cells to migrate (Haas 2005). Endothelial cells 
at the stalk of the sprout continue to proliferate while endothelial cells at the tip of the sprout 
migrate to form a connection with an adjacent pre-existing capillary. This is followed by formation 
of a lumen and stabilization of the new sprout by attachment of pericytes and reconstitution of the 
basement membrane (Flier et al. 1995; Pepper 1997). In intussusceptive angiogenesis, endothelial 
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cells activate and send pillar-like projections into the lumen of the existing vessel which eventually 
splits the vessel into two parallel capillaries (Caduff et al. 1986; Mentzer and Konerding 2014). In 
this process, compared to abluminal sprouting, there is minimal endothelial cell proliferation and 
no need for the MMP degradation of ECM (Zhou et al. 1998). In adults, both of these processes 
are co-ordinated through the integration of chemical signals such as hypoxia, metabolites, growth 
factors and inflammatory factors, and mechanical signals including hemodynamic forces of blood 
and mechanical stretch of muscle. In response to these chemical and mechanical stimuli, an 
angiogenic response can be regulated by the release of pro-angiogenic and anti-angiogenic factors. 
Studies have established that for angiogenesis to occur, pro-angiogenic stimuli must up-regulate 
and overcome the influence of anti-angiogenic factors (Olfert and Birot 2011). 
 
1.2 Angiogenic Regulators 
1.2.1 Vascular Endothelial Growth Factor-A (VEGF-A) 
 VEGF-A is one of the most dominant pro-angiogenic factors and is able to stimulate 
endothelial cells in multiple steps of the angiogenic process (Egginton 2011; Ferrara and Henzel 
1989). VEGF-A is required for the formation of vascular system as lack of a single VEGF allele 
results in embryonic lethality in mice (Carmeliet et al. 1996). Within skeletal muscle and adipose 
tissue, VEGF-A is secreted from multiple cell types, including endothelial cells, myocytes, 
macrophages and fibroblasts (Duffy, Bouchier-Hayes, and Harmey 2013; Maharaj et al. 2006). 
Multiple splice variants of VEGF-A exist, which differ by their ability to bind proteoglycans within 
the extracellular matrix (Neufeld et al. 1996). Secreted VEGF-A is retained within the ECM 
surrounding capillaries and can stimulate endothelial cells upon activation. VEGF-A can be 
expressed  by shear stress (Milkiewicz et al. 2001; Williams et al. 2006), hypoxia (Shweiki et al. 
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1992), and muscle stretch (Milkiewicz et al. 2007). There are 3 VEGF receptors: VEGFR-1, 
VEGFR-2 and VEGFR-3 (Ferrara et al. 2003b). VEGF-A binds two receptors on the surface of 
endothelial cells, VEGFR-1 (membrane bound and soluble) and VEGFR2 which is considered to 
be the major mediator of endothelial cell activation and angiogenesis (Terman et al. 1992; de Vries 
et al. 1992). VEGF-A promotes activation, proliferation and migration of endothelial cells through 
mitogen activated protein kinase (MAPK) and phosphoinositide-3 kinase (PI3K) signaling 
pathways (Bernatchez, Soker, and Sirois 1999; Gerhardt et al. 2003). In a murine model of muscle 
specific VEGF deletion, absence of this pro-angiogenic factor induces muscle capillarity 
rarefaction and is associated with a blunted glucose disposal in response to insulin (Bonner et al. 
2013). 
 
1.2.2 Leptin 
 Leptin, a product of the ob gene, is an adipocyte-secreted cytokine (adipokine) traditionally 
known for its involvement in the regulation of food intake, metabolism, and inflammatory 
responses (Margetic et al. 2002; Scarpace and Zhang 2007). To date, six isoforms of the leptin 
receptors which differ by their cytoplasmic domain length (short or long) have been identified 
(Margetic et al. 2002). The presence of leptin receptors OB-Ra and OB-Rb on the surface of 
endothelial cells and the ability of leptin to stimulate tyrosine kinase-dependent signaling pathways 
suggests that the endothelium is a target for leptin signaling (Sierra-Honigmann et al. 1998). Leptin 
also has been recognized as a modulator of angiogenesis due to its pro-angiogenic influence on 
endothelial cells (Anne Bouloumié et al. 1998; Sierra-Honigmann et al. 1998). Leptin’s angiogenic 
activity has been tested in both in vitro and in vivo angiogenesis models (Anne Bouloumié et al. 
1998). Treatment of HUVECS with a physiological concentration of leptin promotes endothelial 
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cell proliferation and survival (Anne Bouloumié et al. 1998; Sierra-Honigmann et al. 1998). This 
effect is associated with formation of capillary-like structures in in vitro angiogenesis assay. Also, 
leptin has been shown to enhance formation of capillaries in vivo in chick embryos and rat corneas. 
In addition to its direct pro-angiogenic activity, leptin can also promote angiogenesis by 
upregulating VEGF expression and facilitating expression and activity of matrix 
metalloproteinanses (MMP-2 and MMP-9), which are key regulators of sprouting angiogenesis 
(Park et al. 2001; Suganami et al. 2004). Leptin-dependant modulation of angiogenesis is dose-
dependent. When present in high concentrations, leptin can enhance capillary permeability and 
generation of reactive oxygen species, which can promote endothelial cell dysfunction and have 
pathophysiological effects on the tissue vasculature (Bouloumie et al. 1999; Cao et al. 2001). 
 
1.2.3 Thrombospondin-1 (Thbs-1) 
 Thbs-1 is a potent anti-angiogenic factor synthesized and released into the extracellular 
matrix by a variety of cell types including endothelial cells, smooth muscle cells, platelets and 
fibroblasts (Mosher, Doyle, and Jaffe 1982; Raugi et al. 1982). Thbs-1 can inhibit multiple steps 
of the angiogenic process. At low concentrations, Thbs-1 inhibits corneal neovascularization as 
well as proliferation and migration of endothelial cells in vitro (Good et al. 1990; Taraboletti et al. 
1990; Tolsma et al. 1993a). Also, exogenous addition of Thbs-1 blocks the ability of endothelial 
cells to organize into tube-like structures and prevents lumen formation (Tolsma et al. 1997). The 
anti-angiogenic domain of Thbs-1 has been mapped to the second and third type-1 repeats in its 
structure (Iruela-Arispe et al. 1999; Tolsma et al. 1993b). The inhibitory action of Thbs-1 is 
through multiple signaling pathways and through interaction with multiple growth factors and 
proteases (Bornstein 2009).  Thbs-1 binds Fibroblast growth factor 2 (FGF2), Transforming 
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growth factor-beta (TGF-β), VEGF-A and MMP-2 and prevents their pro-angiogenic influence on 
endothelial cells (Iruela-Arispe et al. 1999; Margosio et al. 2008; Rodriguez-Manzaneque et al. 
2001; Schultz-Cherry et al. 1995). Furthermore, binding of Thbs-1 to Cluster of Differentiation 36 
(CD36) promotes EC apoptosis (Jiménez et al. 2000). Compared to wild type mice, Thbs-1 knock-
out mice have increased vascularization documented in several tissues (cardiac and skeletal 
muscle, retina, pancreas), which confirms the role of Thbs-1 as an important inhibitor of 
angiogenesis (Crawford et al. 1998; Malek and Olfert 2009; Wang et al. 2003).  
 
1.3 Arteriole Tone and Remodeling 
1.3.1 Endothelial Nitric Oxide Synthase (eNOS) 
 Within endothelial cells, eNOS catalyzes conversion of L-arginine to L-citrulline and nitric 
oxide (NO) as a by-product (Epstein, Moncada, and Higgs 1993). Expression of eNOS can be 
regulated by multiple stimuli. To name a few, shear-stress (the force of blood flow on the surface 
of endothelial cells), estrogen, and hypoxia have been shown to increase eNOS expression within 
endothelial cells (Arnet et al. 1996; Davis et al. 2001; Hishikawa et al. 1995). Activity of eNOS in 
endothelial cells is regulated by multi-site phosphorylation. One of the main activators of eNOS is 
shear-stress. Shear-stress leads to the activation of Akt which phosphorylates eNOS on ser 1177 , a 
main regulatory site for eNOS activation and production of NO (Fulton et al. 1999; Zeiher et al. 
1999). Also, several factors such as VEGF, estrogen, insulin and bradykinin result in activation of 
the PI3-Akt pathway with consequent phosphorylation of eNOS and generation of NO (Harris et 
al. 2001; Liao et al. 2000; Papapetropoulos et al. 1997). Production of NO is required for dilation 
of blood vessels and regulation of blood flow to the surrounding tissue. In arterioles, NO diffuses 
into SMCs, where it activates guanylate cyclase which mediates the production of cGMP. This 
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promotes calcium uptake into the sarcoplasmic reticulum and induces relaxation of SMCs, thereby 
increasing blood flow via vasodilation. Evidence for the critical role of NO in the regulation of 
vessel tone is based on experiments that show inhibitors of eNOS (e.g. nitro-L-arginine) increase 
vessel resistance and reduce blood flow (Sakuma et al. 1992). Furthermore, eNOS knockout mice 
exhibit deficits in vascular relaxation and develop hypertension and microvascular rarefaction (Dai 
and Faber 2010; Kubis et al. 2002; Liu and Huang 2008). This shows that while vasodilation is a 
major function of NO, endothelial production of NO is also critical for adaptive vascular 
remodeling within the alterations blood flow.  
 
1.3.2 Endothelin-1 (Edn-1) 
 Edn-1 is a dominant endogenous vasoconstrictor mainly produced by endothelial cells 
under physiological conditions (Yanagisawa et al. 1988). Multiple stimuli induce expression of 
Edn-1 within endothelial cells including, hypoxia, hormones (e.g. androgens) and inflammatory 
mediators (Hu et al. 1998; Pearson et al. 2008; Taddei and Vanhoutte 1993). The product of Edn-
1 gene transcription is a pre-pro-edn-1 mRNA which undergoes post-transcriptional cleavage to 
produce big Edn-1. Mature and biologically active Edn-1 is then produced by endothelial 
converting enzymes (Bohm and Pernow 2007; Maguire et al. 1997). The biological effects of edn-
1 are mediated by two receptors subtypes: ETA and ETB. In arterioles, binding of Edn-1 to the 
ETA receptor promotes the outflow of calcium and contraction of SMCs, thereby inducing 
vasoconstriction and reduction of blood flow to the surrounding tissue (Yanagisawa et al. 1988). 
Administration of Edn-1 in humans impairs endothelium-dependant vasodilation. This highlights 
the important interaction between Edn-1 and endothelium-derived factors such as NO in the 
regulation of vessel tone and vascular remodeling (Bourque, Davidge, and Adams 2011). 
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1.3.3 Shear stress and Arteriole Remodeling 
 Vascular endothelial cells are highly sensitive to shear stress. Mechanotransduction of 
endothelial cells, induced by laminar shear stress, is essential for the proper distribution of blood, 
regulation of blood pressure, and maintenance of vessel structure (Chien 2007; Mack et al. 2009). 
In arterioles, an increase in shear stress can alter vascular tone or induce structural remodeling 
depending on the duration of the shear stimulus. Acute stimulation of endothelial cells by shear 
stress, due to a transient increase in blood flow, promotes release of shear responsive stimuli such 
as NO and prostaglandins. This induces vasodilation of arterioles and adequate delivery of 
nutrients to the surrounding tissue (Takahashi et al. 1997). Sustained shear-stress promotes 
structural remodeling of the arterioles, which under physiological conditions, serves as a 
homeostatic response to accommodate increases in flow demand and facilitates delivery of 
nutrients within a growing tissue (Mack et al. 2009). This could result in adaptive outward 
remodeling of arterioles (arterioles with wider lumen), or arteriolarization of tissue capillaries 
(increase in arteriole content). Both of these processes require higher endothelial and smooth 
muscle cell content. In endothelial cells, prolonged shear stress can induce expression of a number 
of signaling molecules such as platelet-derived growth factor B (PDGFB), kruppel-like factor 2 
(KLF-2), and Transforming growth factor-β (TGF-β) (Dekker et al. 2002; Mitsumata et al. 1993; 
Walshe, dela Paz, and D’Amore 2013). The role of these endothelial-derived factors in the control 
of SMC and/or endothelial cell proliferation and integrity of vessel structure have been 
characterized by others. Models of arterial injury have identified TGF-β as a critical regulator of 
smooth muscle cell proliferation and migration (Song et al. 2000). Furthermore, studies have 
shown that deletion of KLF2 or PDGFB genes results in embryonic lethality of mice, due to defects 
in vessel formation and vascular wall stability (Lindahl et al. 1998). Overall, shear-stress induced 
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remodeling of arteriole structure constitutes a control mechanism to maintain vascular homeostasis 
and delivery of substrates to the tissue. 
 
1.4 Skeletal Muscle Angiogenesis  
 Skeletal muscle is a highly plastic tissue and can adapt to changes in contractile activity 
(e.g. exercise and denervation), nutrient supply, and environmental stimuli (e.g. hypoxia) (Flück 
and Hoppeler 2003). These adaptations entail alterations in muscle capillary content which can 
significantly impact local tissue and whole-body metabolism given that skeletal muscle makes up 
~40% of body mass in humans (Olfert et al. 2016). Within skeletal muscle, capillaries run in 
parallel with the longitudinal axis of muscle fibers. Thus, an increase in muscle capillary content 
(angiogenesis) increases the surface area for nutrient and gas exchange, thereby facilitating 
function of individual muscle fibers. Physiological angiogenesis in skeletal muscle has been 
mainly studied in response to repeated exercise since it serves as one of the main angiogenic stimuli 
in vivo (Egginton 2011).  
 Capillary growth in skeletal muscle is initiated when oxygen and nutrient delivery is 
inadequate to meet the metabolic demand of myocytes. This activates a complex array of 
mechanical and metabolic stimuli which can simultaneously activate endothelial cells and promote 
angiogenesis. The mechanical stimuli include muscle stretch and flow-mediated shear stress 
(Egginton et al. 1998; Milkiewicz et al. 2001).  Muscle stretch can alter endothelial cell shape. 
This leads to the activation of integrins and production of growth factors such as VEGF-A, as well 
increases in the activity of MMPs required for extracellular matrix remodeling during angiogenesis 
(Haas et al. 2000; Milkiewicz et al. 2007). Shear stress in capillaries results from increases in blood 
flow by vascular conductance and flow-meditated dilation. Elevated shear stress by administration 
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of vasodilator drugs (α1 adrenergic receptor antagonists) can increase skeletal muscle capillary 
content (Gee, Milkiewicz, and Haas 2010). Actions of shear stress are in part mediated by increases 
in VEGF-A and eNOS expression necessary for endothelial cell proliferation and survival (Baum 
et al. 2004; Wragg et al. 2014). Hypoxia can stimulate angiogenesis via activation of HIF-1 
pathway. HIF-1 is a transcription factor consisting of the subunits HIF-1α and HIF-1β. In 
normoxia, HIF-1α is targeted for degradation. However, hypoxia supresses the degradation of 
HIF-1α, which then stabilizes and gets translocated to the nucleus to induce VEGF-A expression. 
In vitro, hypoxia can promote formation of capillary like structures via VEGF induced 
proliferation and migration of endothelial cells (Shweiki et al. 1992). Furthermore, secretion of 
local metabolites can also exert angiogenic influences within skeletal muscle. For example, 
adenosine and lactic acid can induce proliferation and migration of endothelial cells (Langberg et 
al. 2002; Murray and Wilson 2001). The homeostatic balance between metabolic demand and 
capillary content can be disrupted with inactivity and in various disease conditions such as obesity, 
diabetes and peripheral artery disease. This may be as a result of microvascular dysfunction or a 
decrease in capillary content which will be discussed in further detail in the context of obesity.  
 
1.5 Adipose Tissue Angiogenesis 
Of all tissues in the body, adipose tissue may be the most plastic and has the greatest 
capacity to expand (Corvera and Gealekman 2014). Healthy expansion of adipose tissue requires 
a concomitant increase in the adipose vascular network for a maintained substrate delivery and 
metabolic homeostasis of the tissue. Regulation of adipose tissue angiogenesis relies on reciprocal 
local cues from adipocytes and endothelial cells (Cao 2007). Experimental evidence has shown 
that adipose tissue homogenates and pre-adipocyte condition media can induce angiogenesis in 
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vivo, within cornea and chick chorioallantoic membranes (CAM) (Ledoux et al. 2008; Silverman 
et al. 1988). Adipocyte release of numerous pro-angiogenic factors and pro-angiogenic adipokines 
can stimulate an angiogenic process. Adipocytes are a source of VEGF-A and leptin which can 
stimulate endothelial cell proliferation and migration (Cao et al. 2001). Experiments with 
adipocyte specific deletion of VEGF show decreased vascularization within adipose tissue. 
Conversely, overexpression of VEGF seems to rescue this phenotype by maintaining the 
angiogenic capacity of the adipose tissue (Sung et al. 2013). Furthermore, VEGFR-2 blockade in 
implanted pre-adipocytes reduces tissue angiogenesis, as observed by intravital microscopy 
(Fukumura et al. 2003). This highlights the dominant role of VEGF-A in adipose tissue 
angiogenesis. Adiponectin is another pro-angiogenic adipokine that can enhance the angiogenic 
potential within adipose tissue. Adiponectin can activate Akt signaling within endothelial cells and 
indirectly induce endothelial cell migration and survival (via eNOS phosphorylation and VEGF 
expression) (Ouchi et al. 2004). Furthermore, over-expression of adiponectin within adipose tissue 
of mice increases tissue vascular density and perfusion, as assessed by microsphere injection 
(Aprahamian 2013). Studies have also demonstrated that mature adipocytes secret matrix 
metalloproteinases (e.g. MMP-2 and MMP-9) (Brown et al. 1997), which can facilitate sprouting 
angiogenesis by promotion of ECM degradation. Tissue hypoxia may also have a role in adipose 
tissue angiogenesis.  
Under hypoxic conditions, expression of angiogenic factors VEGF-A and leptin may be 
increased because both of these genes are hypoxia inducible (Grosfeld et al. 2002; Shweiki et al. 
1992). Consistent with this idea, it has been shown that under low oxygen conditions, cultured pre-
adipocytes release leptin, VEGF and MMPs, which can potentially induce an angiogenic response 
(Lolmède et al. 2003). An alternate approach in understanding the influence hypoxia on adipose 
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angiogenesis has been through over-expression or HIF-1 subunits. Overexpression of adipose HIF-
1α fails to induce a pro-angiogenic response and increases adipose tissue inflammation and 
fibrosis instead (Halberg et al. 2009). To date, limited data exist regarding physiological regulation 
of angiogenesis within adipose tissue. The majority of studies documenting adipose tissue 
angiogenesis have been conducted in obese individuals or models of HF-diet obesity, which will 
be discussed in detail in an upcoming section. 
 
1.6 Skeletal Muscle and Adipose Tissue Metabolism 
 Skeletal muscle and adipose tissue are key insulin targets involved in the regulation of 
energy storage and utilization. Insulin is synthesized by β-pancreatic cells and released into the 
vasculature in response to post-prandial glucose influx. Insulin signaling initiates by binding of 
insulin to its receptor (IR) located on the cell membrane (Kahn and White 1988). This leads to the 
phosphorylation and activation of insulin receptor substrates 1/2 (IRS1/2). IRS1/2 can activate two 
main downstream signaling pathways, the phosphatidylinositol 3-kinase (PI3K) pathway and the 
Ras-mitogen-activated protein kinase (MAPK) pathway (Rask-Madsen and Kahn 2012). 
Activation of the PI3K pathway is required for insulin-stimulated glucose transport into myocytes 
and adipocytes (Cheatham et al. 1994). Akt is one of the main downstream targets of PI3K which 
gains full enzymatic activity upon phosphorylation. Phosphorylated Akt stimulates the 
translocation of Glucose Transporter 4 (GLUT4) to the plasma, leading to the uptake of glucose 
(Kupriyanova and Kandror 1999). Within skeletal muscle and adipose tissue, basal uptake of 
glucose can also be facilitated via Glucose trasporter 1 (GLUT1), which does not rely on the 
presence of insulin (Kraegen et al. 1993). However, GLUT4 is the predominant controller of 
glucose influx into myocytes and adipocytes (Ishiki and Klip 2005).  
 13 
 Approximately 80% of insulin-stimulated glucose disposal occurs within skeletal muscle 
(Rask-Madsen and Kahn 2012). Insulin regulates the rate of glucose transport and glycolysis 
mainly through the PI3K-AKT pathway. Healthy skeletal muscle alternates between carbohydrate 
or lipid use (Stump et al. 2006a). In times of glucose abundance, skeletal muscle uses glucose as 
the main source of ATP production (via oxidative phosphorylation), or stores it in the form of 
glycogen. In times of energy deprivation such as low glucose availability or high metabolic 
demand of exercise, skeletal muscle utilizes free fatty acids (FFAs) for energy production. This 
requires break down of muscle triglyceride stores or uptake FFAs from the circulation.   
 The primary function of adipose tissue is synthesis and storage of triglycerides in periods 
of energy excess, and their hydrolysis and release of free fatty acids in periods of energy 
deprivation. <10% of insulin-mediated glucose uptake occurs within adipose tissue (Dimitriadis et 
al. 2011) Similar to skeletal muscle, interaction of insulin with its receptor stimulates the activation 
of the PI3K-AKT pathway and uptake of glucose, where it can be used to synthesize glycerol. 
Within adipose tissue, circulating free fatty acids released from the liver are taken up by fatty acid 
transporters (Schwenk et al. 2010). In a fed state, insulin promotes adipose tissue lipogenesis, 
where glycerol and FFA are used to synthesize triglycerides. This serves as the main reservoir of 
energy for the body and prevents accumulation of lipids within plasma and peripheral organs 
(Newsholme and Dimitriadis 2001). During periods of energy demand, triglycerides are rapidly 
mobilized by the activity of hydrolytic lipases. In adipose tissue, hydrolysis of triglycerides 
depends in large part on the activity of Hormone-sensitive lipase (HSL) (Ahmadian et al. 2007). 
HSL can be phosphorylated and activated via beta-adrenergic stimulation. In adipocytes, 
catecholamines bind to Gs- coupled receptors which in turn activate adenylyl cyclase to generate 
cyclic AMP. Rising levels of cAMP activates protein kinase A (PKA) which can phosphorylates 
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HSL at three serine residues (Jocken and Blaak 2008). Phosphorylated HSL catalyzes triglyceride 
breakdown into FFAs in a process called lipolysis. FFAs can be be utilized by adipocytes for ATP 
production (lipid oxidation) and released as a source of energy and membrane components for 
other organs. In the post-prandial state, insulin inhibits lipolysis which limits FFA release into the 
plasma. Anti-lipolytic actions of insulin are mostly mediated through activation of the 
phosphodiesterase enzymes which lower cAMP levels and activity of PKA as a consequence. 
Overall, skeletal muscle and adipose tissue metabolism is coordinated through integration of 
processes (glycolysis, lipolysis and lipogenesis) that are regulated by the metabolic actions of 
insulin. To carry out such metabolic actions, in addition to a need for a competent insulin signaling 
pathway, insulin must first arrive and have access to the target tissue via the microvasculature. 
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Figure 1.1: Insulin signaling    
Insulin binds to its receptor on the cell membrane. This activates insulin receptor substrates 1/2 
(IRS1/2). IRS1/2 can activate two main downstream signaling pathways, the PI3K pathway and the 
MAPK pathway. Akt is one of the main downstream targets of PI3K pathway. Within skeletal 
myocytes and adipocytes, phosphorylated Akt stimulates the translocation of Glucose Transporter 
4 (GLUT4) to the plasma membrane and uptake of glucose. Within the vascular endothelium, Akt 
promotes production of NO via activation of eNOS. NO induces vasodilation and increases 
perfusion of capillaries and delivery of insulin to the tissue.  
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1.6.1 Vascular Influence on Insulin Signaling and Metabolism 
 Insulin secreted by beta pancreatic cells is released into the circulation. In both skeletal 
muscle and adipose tissue, delivery of insulin to carry out metabolic functions relies on the tissue 
vasculature. This is regulated by the vasculature via hemodynamic changes in blood flow as well 
as microvascular content and function. The first component of insulin delivery is that blood 
carrying the hormone must perfuse the target tissue via arterioles and capillaries. In principal, if 
tissue capillary and arteriole number is higher, there is more blood flow and a higher capacity for 
insulin delivery and insulin signaling within the tissue. Importantly, insulin itself increases blood 
flow by inducing vasodilation of arterioles (Raitakari et al. 1995). Similar to myocytes and 
adipocytes, insulin signaling in the endothelium activates the PI3K-AKT pathway. In endothelial 
cells, this leads to the activation of eNOS and production of NO which then inhibits calcium influx 
into SMCs and induces vasodilation. This has been observed in animal studies using euglycemic 
clamps, showing that increases in plasma insulin concentration increases hind limb blood volume, 
which precedes the activation of the insulin signaling pathway (Raitakari et al. 1995; Vincent et 
al. 2004). However, insulin-stimulated changes in blood flow can be partially reduced by inhibitors 
of eNOS (Vincent et al. 2004). The net increase in blood flow increases perfusion of capillaries 
and enhances insulin arrival to the tissue.  
The second component of insulin delivery to the tissue is that insulin must cross the 
capillaries to reach the interstitium. In muscle and adipose tissue where capillaries have a 
continuous arrangement of endothelial cells joined by cell-cell junctions, insulin can diffuse 
between adjacent endothelial cells or by endothelial transcytosis (Lee and Klip 2016). The role of 
endothelial cells in this step of insulin delivery is less understood and currently under investigation. 
Regardless of the means of insulin transfer across the endothelium, total capillary content can 
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influence the net amount of insulin available to myocytes and adipocytes. A higher capillary 
number within the tissue increases the surface area for transfer of insulin across the endothelium. 
This can facilitate binding of insulin to its receptor and activation of downstream pathways for 
glucose disposal. On the other hand, if there is a reduction in capillary number, total supply of 
insulin to the tissue decreases. This may in turn result in a decrease in tissue responsiveness to 
insulin, thereby compromising systemic insulin sensitivity and glucose tolerance. Insulin’s 
influence on tissue uptake of glucose and metabolism is closely linked to the vascular delivery of 
insulin. Therefore, deficits in skeletal muscle and adipose tissue vascular niche may contribute to 
impairments in the metabolic action of insulin in obesity-induced metabolic dysfunctions. 
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Figure 1.2: Vascular dependent delivery of insulin: influence of blood flow and capillary 
number 
A) Insulin is released from the pancreas and is delivered via tissue arterioles. The net delivery of 
insulin depends on arteriole tone, which is regulated by smooth muscle cells (SMC). Increased 
levels of vasodilators (e.g. NO) paralleled by a decreased release of vasoconstrictors (e.g. edn-1) 
induces vasodilation of arterioles. As a result, blood flow increases, which enhances total insulin 
arrival to the tissue. B) At the level of capillaries insulin must exit the endothelium to reach the 
tissue interstitium. Angiogenesis, induced by an increase in the level of pro-angiogenic factors 
(VEGF-A, Leptin) relative to anti-angiogenic factors (e.g. THBS-1) increases capillary number 
within the tissue. A higher capillary number increases the surface area for transfer of insulin across 
the endothelium, which can facilitate binding of insulin to its receptor and activation of 
downstream pathways for glucose disposal.  
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1.7 Obesity-induced Metabolic Dysregulation: The Vascular Side 
 Obesity is a multifactorial condition associated with the development of ectopic lipid 
accumulation, resistance to metabolic stimuli, and chronic systemic inflammation. Central 
adiposity is closely associated with an increased risk in the development of metabolic disorders 
such as insulin resistance and type 2 diabetes (Martyn, Kaneki, and Yasuhara 2008). Insulin 
resistance refers to impairments in the tissue response to insulin. In both skeletal muscle and 
adipose tissue, this leads to deficits in insulin’s regulation of glucose and fatty acid metabolism 
and dysregulation of metabolic processes mentioned earlier. The majority of experimental studies 
documenting the deleterious effects of a high-fat diet have mainly focused on tissue metabolism 
and overlooked the critical role that tissue capillaries and arterioles play the maintenance of insulin 
delivery and tissue metabolic function. Over the past few decades, a link between the tissue 
microvascular content and function, exchange of metabolic stimuli and insulin sensitivity has been 
recognized (Barrett et al. 2009; Frisbee et al. 2006; Goodwill and Frisbee 2012). Also, a growing 
body of evidence has shown that vascular dysfunction occurs prior to, or in parallel to, conditions 
such as insulin resistance and type II diabetes (Kim et al. 2008; Natali et al. 2006). In insulin 
resistant states, endothelial dysfunction at the levels of tissue arterioles has been shown to reduce 
blood flow to the muscle. This involves reduced vasodilation due to increases in the production of 
reactive oxygen species (ROS) paralleled with impairments in endothelial NO production 
(Goodwill and Frisbee 2012; Xiang et al. 2008). Furthermore, increases in the release of fatty 
acids, as occurs in obesity, can impair endothelial production of NO and further reduce delivery 
of insulin to the tissue (Steinberg and Baron 2002). Although impairments in the delivery of insulin 
via tissue arterioles has gained attention (Muniyappa and Quon 2007), only few studies have 
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examined the impact of HF diet-induced obesity on tissue capillary content, which is the focus of 
the next two sections.   
 
1.7.1 Skeletal Muscle Capillaries: Influence of Obesity 
 Capillary number and distribution within a muscle must be sufficient to maintain a balance 
between nutrient supply and metabolic demands of the myocytes. In some pathological conditions, 
this balance gets disrupted, in which case the capillary network fails to maintain perfusion of 
myocytes. Several studies have shown that skeletal muscle capillary content is reduced (capillary 
rarefaction) in conditions of HF diet-induced obesity, insulin resistance or diabetes. In rodent 
studies, capillary density and capillary-to-fiber ratio is significantly decreased within skeletal 
muscle of diet-induced obese diabetic male animals (Frisbee 2003; Frisbee et al. 2006; Kivela et 
al. 2006; Kondo et al. 2011). This pattern is also evident in humans as capillary density has been 
shown to be inversely correlated with waist circumference and decreased in the muscle of obese 
and diabetic males (Gavin et al. 2004; Lillioja et al. 1987). Such reductions in microvascular 
content in turn are closely linked to impairments in skeletal muscle insulin responsiveness 
(Solomon et al. 2011). Insulin-stimulated blood flow and glucose uptake have been shown to be 
proportional to capillary density, meanwhile, fasting glucose and insulin levels are inversely 
related to capillary density (Hedman et al. 2001; Krotkiewski et al. 1983; Lillioja et al. 1987). A 
reduction in muscle capillary content may be due to capillary rarefaction, or restraint in the growth 
of new capillaries. A high-fat diet may reduce muscle capillary content by promoting an angiostatic 
microenvironment, which in turn contributes to disturbances in the metabolic pathways of skeletal 
muscle. For example, levels of Thbs-1 have been shown to increase in the plasma and muscle of 
male mice fed a high-fat diet (Inoue et al. 2013). Importantly, the majority of studies that have 
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reported a reduction in muscle capillary content have used models of obesity associated with 
diabetes or insulin resistance (Frisbee et al. 2006). In this case the skeletal muscle response may 
be more severe because diabetes can repress an angiogenic response by inducing tissue 
inflammation and production of reactive oxygen species which can promote endothelial cell 
dysfunction and apoptosis (Fridlyand and Philipson 2006; van den Oever et al. 2010).  
 Conversely, some studies have reported a lack of change or an increase in capillary content 
within skeletal muscle of rodents fed a HF diet. Roudier et al. have shown that capillary density 
and capillary-to-fiber ratio does not change within plantaris muscle of female rats fed a HF diet 
(Roudier et al. 2009). However, in a mouse model of chronic HF feeding, Silvennoinen et al. 
reported that HF diet induces angiogenesis and increases capillary content within skeletal muscle 
of male mice. This was paralleled with an increase in VEGF-A and HIF-1 mRNA expression 
within endothelial cells of HF fed animals. However, within the muscle homogenate, only VEGF-
A protein levels were increased (Silvennoinen et al. 2013). Thus currently, there is mixed evidence 
regarding the influence of obesity on skeletal muscle angiogenesis. The majority of present data 
suggests a reduction in capillary content when obesity is associated with metabolic dysfunctions 
such as type 2 diabetes. However cellular mechanisms underlying this reduction remain to be 
identified. Therefore, more research is needed to build a comprehensive knowledge regarding 
influence of HF diet-induce obesity on capillary adaptations within skeletal muscle.  
 
1.7.2 Adipose Tissue Capillaries: Influence of Obesity 
 Expansion of adipose tissue requires an increase in tissue vascularization for the 
maintenance of metabolic homeostasis. However, in obesity, adipose capillary content may not 
keep pace with the rapid growth of visceral white adipose tissue (Goossens and Blaak 2015). In 
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obese humans and rodents, adipose tissue blood flow is significantly reduced, which correlates 
with a decrease in adipose tissue capillary density (Gealekman et al. 2011; Goossens et al. 2011; 
Hosogai et al. 2007; Pasarica et al. 2008). A reduction in blood flow may be accompanied by 
adipose tissue hypoxia in obese individuals (Pasarica et al. 2009). Low oxygen tension within 
adipose tissue of genetically obese mice (e.g. ob/ob mice) and mouse models of diet induced 
obesity has also been observed using needle-type O2 sensors or by measurement of hypoxia 
marker pimonidazole (Hosogai et al. 2007; Rausch et al. 2008; Trayhurn and Alomar 2015). Under 
physiological conditions, this should lead to the stabilization of HIF-1, upregulation of VEGF-A 
protein, and a concomitant increase in tissue angiogenesis. However, VEGF-A level does not 
increase within adipose tissue of obese male mice (Voros et al. 2005). In obesity, hypoxia seems 
to have a primary role in triggering a pro- inflammatory and fibrotic environment within the 
adipose tissue  (Corvera and Gealekman 2014; Halberg et al. 2009). For example, an increase in 
the production of pro-inflammatory adipokines (e.g. leptin) and activation of tissue macrophages 
can induce production of tumor necrosis factor-α which can induce endothelial cell apoptosis, 
resulting in capillary rarefaction (van der Heijden et al. 2015). Studies have shown an up-
regulation in gene expression of anti-angiogenic factors such as THBS-1 within adipose tissue of 
animals on a high-fat diet (Moraes et al. 2003; Voros et al. 2005). Upregulation of anti-angiogenic 
along with a lack of hypoxia-induced VEGF expression may suggest that in obesity, anti-
angiogenic pathways may overcome pro-angiogenic pathways, further contributing to capillary 
rarefaction. To date, mechanisms underlying the failure of an angiogenic response within adipose 
tissue of obese and insulin resistant individuals have not been established.  
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1.8 Sex Differences in Obesity-Related Metabolic Disorders 
 In most industrialized countries, the increased prevalence of obesity and comorbidities 
associated with it is a major health concern. Although both males and females are affected, the 
susceptibility to develop obesity-related metabolic disorders is higher in males (Fuente-Martín et 
al. 2013; Kanter and Caballero 2012; Power and Schulkin 2008; Shi et al. 2012). In developed 
countries, more males are obese versus pre-menopausal females (Kanter and Caballero 2012). This 
coincides with a higher prevalence of insulin resistance, hypertension, and dyslipidemia in males 
compared to females (Beigh and Jain 2012; Eliza B. Geer and Shen 2009). In a report released by 
Statistics Canada, 62% of men versus 46 % of women have an increased health risk due to excess 
weight gain (http://www.statcan.gc.ca/pub/82-625-x/2015001/article/14185-eng.htm). In 
experimental animal models, the metabolic challenge of a HF diet induces more weight gain in 
males compared to females (Benz et al. 2012; Hong et al. 2009a). Moreover, with chronic 
consumption of a HF diet, male rodents are more often to develop severe hypertension, systemic 
glucose intolerance and insulin resistance (Benz et al. 2012; Renee E. Stubbins et al. 2012). 
Interestingly, even in a study of weight matched male and female mice, HF-fed females maintain 
a better glucose tolerance compared to HF-fed male mice (Nickelson et al. 2012). 
 
1.8.1 Mechanisms Involved in Sex-specific Influence of Obesity 
 To date, established molecular mechanisms responsible for the sex-specific responses to a 
high-fat diet and obesity are limited. Differences in patterns of fat distribution and metabolism 
may be one of the underlying reasons for sex-dependent differences in the metabolic risk of 
obesity. Pre-menopausal females have a lower waist-to-hip ratio and predominantly accumulate 
subcutaneous adipose tissue, whereas males store more fat in the visceral region (Kotani et al. 
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1994; Lönnqvist et al. 1997). Studies have shown that higher visceral adiposity substantially 
increases the risk of insulin resistance and is correlated with mortality from cardiovascular and 
metabolic disorders (Björntorp et al. 1997; Kaplan 1989). Therefore, accumulation of visceral 
adipose tissue may predispose males to the development of the aforementioned disorders. 
Furthermore, visceral adipose tissue of female rats has been shown to have a higher lipolytic 
capacity compared to males (Lladó et al. 2002). This is accompanied by a lower expression of 
hormones involved in lipid hydrolysis (i.e. HSL) in the adipose tissue of males (Stubbins et al. 
2012). Thus, in females, fat accumulated within visceral adipose tissue may be more easily 
oxidized or mobilized as a source of energy for other organs. In addition, FFA uptake is higher in 
subcutaneous adipose tissue of pre-menopausal females than in males (Shadid et al. 2007). This 
may in turn contribute to lower levels of circulating lipids, lower ectopic fat accumulation and an 
improved metabolic status in females compared to males during weight gain. 
 HF diet-induced adipose tissue expansion is also accompanied by sex differences in 
inflammatory responses. Production of pro-inflammatory cytokines is higher in the skeletal muscle 
and adipose tissue of male mice compared to female mice (Estrany et al. 2013). A HF diet results 
in greater increases in TNF- and IL 6 in male compared to female mice (Estrany et al. 2013; Taylor 
and Sullivan 2016). Also, the presence of crown–like structures (macrophages surrounding 
apoptotic cells) is significantly higher within adipose of HF-fed male compared to HF-fed female 
mice (Nickelson et al. 2012). Females are reported to have higher levels of adiponectin, which is 
an anti-inflammatory cytokine (Cnop et al. 2003). In mice, a HF diet induces a decrease in 
adiponectin levels in males, whereas, in females adiponectin levels are maintained (Nickelson et 
al. 2012).  
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 Notably, following menopause and the decline in estrogen levels, females gain more 
visceral adiposity and have an increased risk to develop insulin resistance (Catalano et al. 2008; 
Toth et al. 2000). In experimental models, ovariectomized female mice mimic male mice in their 
propensity to develop weight gain and insulin resistance (Hong et al. 2009a). This brings forth the 
protective role of estrogen in the development of metabolic dysfunctions (Riant et al. 2009).  
Estrogens act through two nuclear receptors ERα and ERβ. Loss of ERα signaling has been shown 
to exacerbate the adverse effects of a HF diet and insulin resistance in both skeletal muscle and 
adipose tissue of female rats (Gorres et al. 2011). The beneficial effects of estrogen in the 
maintenance of insulin sensitivity is mediated by different mechanisms. Estrogen has direct effects 
on insulin-mediated uptake of glucose by increasing expression of GLUT4 (Rüegg et al. 2011). 
Furthermore estrogen may have anti-inflammatory properties, since expression of inflammatory 
cytokines (e.g. TNF and IL6) is significantly reduced with estrogen treatment in ovariectomized 
rats compared to their untreated counterparts (Arenas et al. 2005). However, effects of estrogen 
therapy in post-menopausal women is controversial and estrogen therapy does not significantly 
improve the metabolic status of  obese woman (Ryan et al.  2002; Saglam 2004). This suggests 
that a higher level of estrogen alone is not the only contributor to a maintained metabolic profile 
in females.  
 Overall, sex-related differences in HF diet-induced weight gain and metabolic function 
likely are multifaceted. Capillaries within skeletal muscle and adipose tissue are critical regulators 
of metabolic homeostasis, enabling the appropriate exchange of gasses, hormones and energy 
sources. Thus, their content and phenotype can influence the overall health of the tissue. To date, 
most of what we know about the influence of a high-fat diet on tissue capillary beds is from studies 
that have investigated only 
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investigating sex-associated differences in obesity have predominantly focused on tissue 
metabolism and fat distribution, while the microvascular contribution to these differences has been 
overlooked. In this context, the goal of this project is to examine if a high-fat diet influences the 
vascular niche of male and female skeletal muscle and adipose tissue in a sex-dependent way and 
whether this can be linked to differences in obesity-related metabolic complications. 
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1.9 Study Objectives 
 
1. To examine if exposure to a HF diet alters muscle and adipose tissue responsiveness to metabolic 
stimuli in a sex-specific manner. 
 
2. To examine if sex-related differences exist in microvascular content within the muscle and 
adipose tissue of male and female mice on a normal diet or under the metabolic stress of a HF diet. 
 
 
 
1.10 Hypotheses: 
 
1. Sex-dependent differences in angiogenic responsiveness exist in skeletal muscle and adipose 
tissue of male and female mice on a high-fat diet.  
  
2. This contributes to a worsened metabolic profile in males compared to females. 
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Chapter 2: Methods 
 
2.1 Ethical Approval  
Animal studies were approved by York University Committee on Animal Care, and performed in 
accordance with the Canadian Council for Animal Care Guidelines. 
 
2.2 Mouse Model of High-fat Diet-induced Obesity  
FVB/B6 Mouse colonies were initiated and maintained in York University vivarium on a 12-hour 
light-dark cycle. Male and Female mice at 6-8 weeks of age were placed on a High-fat (HF) or a 
calorie matched normal chow (NC) diet for 16 weeks (n=8 per group). The HF diet consisted of 
58 kcal% fat, 25.5% carbohydrate and 16.4% protein and the NC Diet consisted of 10.5 kcal% fat, 
73.1% carbohydrate and 16.4% protein (D12331 and D12329 respectively; Research Diets Inc., 
NJ, USA). Water and food was provided ad libitum. Body weight and food consumption were 
recorded weekly. Body weight gain was calculated over 14 weeks (week 14 -week 0). Total Kcal 
consumed calculated by multiplying grams of food consumed by kcal/g (NC: 4.07 kcal/g, HF 5.56 
kcal/g) averaged over 14 weeks. Feed efficiency, which is the amount of kcal needed to gain 1 g 
of weight, was calculated by dividing cumulative weight gain by cumulative kcal consumed over 
14 weeks. Systemic glucose handling characteristics of the mice were assessed by insulin and 
glucose tolerance tests on weeks 8, 14 and 15. Blood pressure and heart rate were recorded using 
a non-invasive tail-cuff pressure system (CODA surgical monitor, Kent Scientific, CT, USA) on 
week 13, while mice were lightly sedated by isoflurane inhalation and body temperature was 
maintained by placing mice on a heat pad. Animals were allowed to recover at least 72 hours after 
which hind-limb skeletal muscles and visceral adipose tissue were removed under isoflurane 
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anesthesia. Tissues were weighed and snap frozen in liquid nitrogen for biochemical analyses, or 
frozen in cooled isopentane for histology and kept at -80°C. Mice were euthanized by 
exsanguination. 
 
2.3 Systemic Metabolic Profiling 
Insulin tolerance tests (ITT) were conducted during diet weeks 8 and 14 after 4 hours without food. 
Fasted blood glucose levels were measured before mice receive intraperitoneal (IP) injections of 
insulin (0.75U/kg body weight, Humalog, Lilly, ON, Canada). Blood glucose levels were 
measured 20, 40 and 60 minutes post insulin injection. Glucose tolerance test (GTT) was taken on 
week 15 after 16 hours without food. Fasted blood glucose levels were measured before IP 
injections of glucose (1.75g/kg body weight, D-(+)-Glucose dissolved in ddH2O, Sigma Aldrich 
Co., MO, USA). Blood glucose levels were measured 30, 60, 90, 120, and 180 minutes post 
glucose injection. For both tests, blood was collected by saphenous vein puncture and blood 
glucose levels were measured with a glucometer (Freestyle Lite, Abbott Diabetes Care, ON, 
Canada). IP-ITT: Blood glucose levels relative to baseline (time 0) were graphed over time and 
glucose response curve was calculated using baseline glucose levels as reference for each animal 
(Area over curve-AOC).  IP-GTT: blood glucose values were graphed over time and the area of 
the glucose response curve was calculated using baseline glucose levels as reference for each 
animal (Area under curve-AUC). 
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2.4 In vivo and ex vivo Functional Analysis 
Insulin stimulation of skeletal muscle was conducted in-vivo while mice were maintained under 
isoflurane anesthesia. One extensor digitorum longus (EDL) muscle was collected and snap frozen. 
The mice were then injected intraperitoneally with 0.12 U of insulin (0.25U insulin/ ml of sterile 
HEPES-saline). After 15 minutes, EDL from the contralateral leg was removed and snap frozen in 
liquid nitrogen for protein analysis.  
Ex-vivo stimulation of visceral white adipose was conducted by surgically removing a portion of 
perigonadal adipose prior to insulin injection. This adipose was divided into 3 portions (~80 mg 
each) and pre-incubated in low-glucose DMEM containing 1% fatty-acid free Bovine serum 
albumin (BSA; Sigma Aldrich, #A8806-5G, ON, Canada) for 30 minutes at 37°C, followed by 
addition of insulin (25mU/ml), isoproterenol (0.1mM, #1747 Tocris Bioscience, Bristol, UK) or 
vehicle and incubation at 37°C for 30 minutes. At the end of the incubation, depots were snap 
frozen in liquid nitrogen for protein analysis.  
 
2.5 Skeletal Muscle Immunohistochemistry 
10 µm cryo-sections of EDL muscle were fixed in 3.7% formaldehyde in 1x PBS for 20 minutes. 
Sections were blocked using 5% goat serum (#318773, Thermo Fisher Scientific, MA, USA) and 
0.01% triton in 1x PBS for 30 minutes. Sections were stained for 1 hour with fluorescein 
isothiocyanate-conjugated Griffonia Simplicifolia Lectin-1 (1:100; Vector Labratories, ON, 
Canada) to detect capillaries and Rhodamine Wheat Germ Agglutinin (1:1000; Vector Labratories, 
ON, Canada) to detect muscle fibers. Sections were washed with 1xPBS, mounted on coverslips 
and placed in a moist dark area over night. Slides were viewed using an Axiovert 200M Zeiss 
microscope with 20x objective. Images were captured using a cooled CCD camera and Metamorph 
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imaging software. The numbers of capillaries and fibers in 3-4 independent fields of view were 
counted for each animal. Capillary-to- fiber ratio was calculated as a measure of skeletal muscle 
capillary content. Capillary number was quantified as capillary density (#capillaries/mm2) and 
myocyte cross-sectional area was calculated by image thresholding on the ImageJ software 
 
2.6 Adipose Tissue Histology 
Visceral white adipose tissue from the perigonadal region was sectioned into small pieces (~1 
mm3) and incubated with Bodipy® 493/503 (0.25ug/ml; Molecular Probes, Thermo Fisher 
Scientific, MA, USA ) as a lipid droplet marker and Rhodamine Griffonia Simplicifolia Lectin-1 
(1:100 dilution; Vector Laboratories, ON, Canada) as an endothelial cell marker for 20 minutes 
and shielded from light. Samples were washed 3 times with 1x PBS (10 minutes per wash). Whole-
mount adipose tissue was visualized using a Zeiss LSM 700 confocal microscope with 10x 
objective. Setting one channel for lectin and another for Bodipy®, an average of 4 scans were 
taken from the same focal plane using the speed of 3 to ensure optimal quality of images. 3-4 
independent fields of view were selected randomly for each animal. Percent area of field of view 
(% FOV) covered by lectin (as an indicator of tissue capillary content) was quantified by image 
thresholding, and Vessel diameter and number of branch points were quantified on the ImageJ 
software.  
 
2.7 Protein Extraction  
 Protein was extracted using 20-30 mg of frozen skeletal muscle (EDL and EHP) or visceral white 
adipose tissue (perigonadal adipose region) in Radio immunoprecipitation assay (RIPA) lysis 
buffer containing 1X protease inhibitor cocktail (Complete mini; Roche Diagnostics, QC, Canada) 
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and 1X phosphatase inhibitor cocktail (PhosSTOP; Roche Diagnostics, QC, Canada). Tissue Lysis 
was performed using a Retsch MM400 tissue lyser (GmbH, Haan, Germany) and metal beads, 
followed by one hour of agitation at 4°C. Samples were then centrifuged at 12,000g (Heraeus 
Biofuge Stratos, Thermoscientific, ON, Canada) for 20 minutes at 4°C to remove cell debris. 
Supernatant was collected and stored at -80°C.   
 
2.8 Protein Quantification 
Protein extracts were quantified by bicinchoninic acid assay (BCA) (Pierce, Fisher 
Thermoscientific, ON, Canada). Lysates were loaded in duplicates on 96 well plates with working 
reagent and compared to a standard curve using serial dilutions of bovine serum albumin (BSA: 
0-2000ug/ml, Pierce, Thermo Fischer scientific, ON, Canada). Sample absorbance at 562nm was 
measured using the Cytation3 microplate reader (BioTek, Vermont, USA).  
 
2.9 Western Blot 
20-30 ug of total protein per sample, as determined by BCA, was prepared in 4xDTT leading buffer 
containing 0.72M β-mercaptoethanol, 69.4mM sodium dodecyl sulfate, 2.74M glycerol, 14.29 µM 
bromophenol blue, 62.4 mM Tris pH 6.8, and RIPA lysis buffer as a diluent. Samples were boiled 
for 5 minutes, centrifuged, and placed on ice. The prepared lysates were loaded (20-25µg per lane) 
and separated through 8% or 10% SDS-Polyacrylamide gel electrophoresis under reducing 
conditions. Proteins were transferred on a polyvinylidene difluoride (PVDF) membrane 
(Immobilon P, EMD Millipore, ON, Canada) using wet transfer at 100V for varying durations, 
depending on the molecular weight of the protein of interest. Membranes were blocked for one 
hour with 5% milk in a 0.05% Tween Tris buffered saline solution (TTBS). After Blocking, 
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membranes were incubated with primary antibodies [Phospho-Akt-ser 473 (1:1000 dilution; 
#4058, Cell Signaling, ON, Canada), Akt (1:1000; #9272, Cell Signaling), Phospho-HSL-Ser563 
(1:1000; #4139, Cell signaling), HSL (1:1000;  #4107, Cell Signaling), αβ-Tubulin (1:1000; 
#2148, Cell Signaling) and β-Actin (1:1000; #Sc-47778, Santa Cruz Biotechnology, CA, USA)] 
in 5% BSA (Bioshop, Canada Inc, ON, Canada) in 0.05% TTBS overnight at 4°C. The following 
day, membranes were washed with TTBS and incubated with secondary antibodies [goat anti-
rabbit IgG-horseradish peroxidase (1:10000 dilution, #111-035-003, Jackson ImmunoResearch 
Laboratories Inc., USA) and goat anti-mouse (1:10000; 115-165-003, Jackson ImmunoResearch 
Laboratories Inc., USA) in 5% BSA for 1 hour at room temperature. The antibodies were detected 
by enhanced chemiluminescence (Pierce, Thermo Fischer Scientific, ON, Canada) using 
Microchemi DNr Bio-imaging system (Neve Yamin, Israel). Blots were quantified and analyzed 
using Image J software which determines density values based on the net intensity of each band. 
For each sample, the raw value obtained from the protein of interest was divided by the raw value 
obtained from the loading control. Relative intensity values were used for statistical analyses.  
 
2.10 RNA Extraction 
10-15 mg of frozen tibialis anterior (TA), EDL muscle, and visceral white adipose tissue were 
homogenized in RLT (muscle) or Qiazol buffer (adipose) (Qiagen, ON, Canada) using the Retsch 
MM400 tissue lyser. Total RNA was purified using the RNeasy Fibrous Tissue Mini Kit for muscle 
and RNeasy Mini Kit for Adipose (74704 and 74104, Qiagen, ON, Canada) as per the 
manufacturer’s instructions.  
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2.11 q-RT PCR  
For each sample, 190 ng of RNA was reversed transcribed to cDNA in a two-step PCR reaction 
on a Thermal cycler (2720 cycler, Applied Biosystems, CA, USA) using [dNTP (#N0447S, New 
England Bioabs, ON, Canada), Oligo DT (#100002344 Invitrogen, CA, USA), Ribolock RNase 
inhibitor (#EO038, Thermo Fisher Scientific, MA, USA), Random hexamers (#100026484, 
Invitrogen, CA, USA), M-MuLV reverse transcriptase and buffer (New England BioLabs, ON, 
Canada)]. The cDNA was diluted in 40 µl of RNase free water. 2 µl of cDNA was combined with 
Taqman® Fast Advanced Master Mix (#4444557, Applied Biosystems, Thermo Fisher Scientific, 
CA, USA) and TaqMan® FAM-Labelled probe sets for murine Hprt1 (Mm00446968-m1), 
βactin(Mm004394036-g1), Pecam1 (Mm00476712-m1), Vegfa (Mm00437306-m1), NOS3 
(Mm00435217-m1), Leptin (Mm00434759-m1), Slc2a1 (Mm00441480-m1), Edn1 
(Mm00438656-m1), Thbs1 (Mm001335418-m1), adipoq (Mm00456425-m1), Klf2 
(Mm00500486-m1), Pdgfb (Mm00440677-m1), Tgfβ1 (Mm01178820-m1). q-RT PCR was 
performed using the PCR cycler Rotor-Gene Q system (Qiagen, ON Canada) in the following 
thermal conditions: 60 °C for 30 minutes, 95 °C for 10 minutes for 40 cycles. Samples were 
assessed in duplicates. To determine the amount of target sample mRNA, the average cycle 
threshold (CT) was calculated and compared to the average CT of Hprt1 or βactin (housekeeping 
genes) for the same samples with the formula ΔCT= Average CT (gene of interest)- Average CT 
(housekeeping gene). The amount of target gene amplification relative to the control was 
calculated using the formula 2^-Δ CT.  
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2.12 Statistical Analysis 
Results were presented as Mean ± S.E.M. Analyses was done by unpaired student’s t-test and two-
way ANOVA followed by Bonferroni post hoc tests as appropriate (Prism5; Graphpad software 
Inc; La Jolla, CA, USA). In all cases, p< 0.05 was considered statistically significant. 
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Chapter 3: Results 
3.1 Sex Differences in Body Weight and Energy Intake Following HF Diet-induced Obesity  
Male and Female FVB/B6 mice were placed on a 16week high-fat diet to induce weight 
gain and metabolic disturbances (Fig. 3.1A). Weight gain was significantly higher in HF male vs. 
NC male mice (Fig. 3.1B). Meanwhile, there was no significant difference in weight gain between 
NC- and HF-fed females (~7g weight gain in both groups). Consistent with the existing literature 
(Hong et al. 2009b), weight gain was significantly lower in HF female compared to HF male mice. 
This was in accordance with lower total calorie (kcal) consumption of females compared to males 
in both NC and HF diet groups, although, HF-fed males and females consumed more calories 
relative to their NC-fed counterparts (Fig. 3.1C). Furthermore, cumulative feed efficiency, which 
is the amount of calories needed to gain one gram of body weight, was significantly lower in HF 
female vs. HF male mice (Fig. 3.1D).  
There was no significant effect of diet on the absolute weights (mg) of hindlimb muscles 
of male or female mice (Table 3.1). As expected, females had smaller EDL, gastrocnemius, and 
plantaris muscles compared to males. When taking body weight into consideration, all hindlimb 
muscles, except soleus, weighed less in HF male vs. NC males (Table 3.2). However, no 
significant difference was found in the relative hindlimb muscle weights (mg/ g body weight) of 
NC- and HF-fed females. The absolute weights of visceral white adipose tissue from both 
perigonadal and retroperitoneal regions were significantly higher in HF males compared to NC 
males. In females however, there was no significant change in the weight of these regions 
following HF feeding. Absolute adipose tissue weight (perigonadal, retroperitoneal and BAT) was 
significantly lower in HF females compared to HF males, meanwhile, relative adipose tissue 
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weight was not significantly different between groups. HF feeding also increased the mass of heart 
and liver in males but not females. HF females had significantly smaller heart and liver compared 
to HF males. This difference in sex was absent in animals fed a NC diet, although, the relative 
weights of HF female hearts were significantly higher compared to HF male mice, which is 
accounted for by a lower overall body weight in females.  
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3.2 Glucose Handling and Blood Pressure Maintained in HF Female but not HF Male Mice  
 Next, we examined whether this model of HF diet-induced obesity induces systemic 
cardiovascular and metabolic disturbances in male and female mice. There was no influence of 
diet on heart rate in either sex (Fig. 3.2A). However, systolic and diastolic blood pressures were 
significantly increased in HF males but not HF females when compared to their NC-fed 
counterparts (Fig. 3.2B, C). Fasted plasma glucose level was significantly lower in HF female 
compared to HF male mice, in whom fasting plasma glucose was significantly increased by the 
HF diet (Fig. 3.2D). Following an IP-GTT test, HF male mice exhibited impaired glucose tolerance 
compared to HF female mice who maintained a response similar to the NC-fed groups. GTT-AUC 
was significantly higher in HF male vs. HF female mice due to a higher peak in plasma glucose, 
and glucose levels remaining higher during the following 3 hours after glucose injection (Fig. 
3.2E, F). Skeletal muscle and adipose tissue are both metabolically active tissues involved in the 
regulation of whole-body metabolism and glucose disposal. In both of these tissues, glucose uptake 
may occur by both insulin dependent and insulin independent mechanisms. Basal uptake of 
glucose is facilitated by the insulin independent Glucose Transporter 1 (GLUT1) (Kraegen et al. 
1993).  To examine whether differences in glucose tolerance were associated with GLUT1 levels, 
I measured GLUT1 mRNA in both EDL muscle and perigonadal adipose tissue. In the EDL 
muscle, there was a trend for higher GLUT1 mRNA levels in HF females compared to HF males 
(overall sex effect p=0.06) (Fig. 3.2G). In adipose tissue, GLUT1 mRNA level was significantly 
higher in HF vs. NC males and there was a trend for lower GLUT1 expression in female compared 
to male mice (Fig. 3.2H). 
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3.3 Systemic and Skeletal Muscle Sensitivity to Insulin Maintained in HF Female Mice 
Changes in glucose tolerance may in large part depend on differences in the insulin-
dependent uptake of glucose. Following an IP-ITT test, HF male mice demonstrated an impaired 
capacity to lower their plasma glucose levels in response to the injected insulin, as characterized 
by a lower ITT-AOC in HF vs. NC male mice.  In contrast, HF females maintained a response 
similar to their NC counterparts and the ITT-AOC was significantly higher in HF female compared 
to HF male mice (Fig. 3.3A, B). The majority of insulin-induced glucose uptake occurs within 
skeletal muscle (Leto and Saltiel 2012). However, to have this metabolic effect, insulin in the 
circulating blood must first be delivered via capillaries, then exit the vessel wall to reach the tissue 
(Lee and Klip 2016). Thus the insulin-dependent activation of downstream pathways (i.e. Akt 
pathway) relies on the vascular delivery of insulin to the target tissue. Consequently, sex 
differences in systemic insulin sensitivity may involve differences in skeletal muscle 
responsiveness to insulin via altered delivery of insulin by the muscle microvasculature. In animals 
fed a NC diet, both males and females exhibited a similar level of phosphorylated Akt in response 
to in-vivo delivery of insulin (Fig. 3.3C). In contrast, insulin stimulation resulted in significantly 
greater Akt phosphorylation within the muscle of HF females compared to HF males (Fig. 3.3D). 
Together, these findings indicate that systemic and skeletal muscle response to insulin is preserved 
in females but impaired in males in response to a HF diet. 
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3.4 Adipose Tissue Sensitivity to Insulin and Isoproterenol Maintained in HF Female Mice 
To examine if the male and female response to stimuli involved in metabolism is also 
different in visceral white adipose tissue, we stimulated fat from the perigonadal region with 
insulin or isoproterenol. Within adipose tissue, insulin induces the storage of lipids (Rosen and 
Spiegelman 2006), meanwhile, isoproterenol, as a β-adrenergic agonist, stimulates the breakdown 
of lipids through the process of lipolysis (Lafontan et al. 1997). Insulin-dependent phosphorylation 
of Akt in the adipose tissue was similar between males and females on a NC diet (Fig. 3.4A). In 
contrast, in animals fed a HF diet, phosphorylated Akt levels were significantly increased only in 
female mice. Moreover, HF female mice had significantly higher pAkt levels compared to HF 
male mice, suggesting that on a HF diet, visceral white adipose tissue of females is more sensitive 
to insulin compared to males (Fig. 3.4B).  
Hormone-sensitive lipase (HSL) has been established as a downstream effector of β- 
adrenergic receptor signaling (Lafontan et al. 1997). In response to ex-vivo isoproterenol, 
phosphorylation of HSL was significantly increased in the adipose tissue of NC male and NC 
female mice (Fig. 3.4C). Phosphorylated HSL was also significantly increased in male and female 
animals fed a HF diet, however, this response was significantly higher in HF females compared to 
HF males (Fig. 3.4D). Together, these results confirm that HF feeding influences the white adipose 
tissue of male and female mice differently. In HF male mice adipose tissue response to insulin and 
isoproterenol was compromised, whereas HF female adipose tissue response to these stimuli was 
maintained. 
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3.5 Adipokine Profile of Visceral White Adipose Tissue is Different in Male vs. Female Mice 
 Male and female adipose response to metabolic stimuli may be influenced by HF diet 
induced alterations in the release of adipokines. It has been previously reported that mRNA levels 
of leptin are significantly lower in the inguinal and mesenteric white adipose tissue of females 
compared to males on a NC or a HF diet (Priego et al. 2009). Our results confirm that on a HF 
diet, mRNA expression of leptin is significantly lower in the prigonadal white adipose tissue of 
HF female vs. HF male mice. However, in the NC-fed mice, leptin mRNA levels were not 
significantly different between males and females. Moreover, a significant increase in leptin 
mRNA expression was only observed in the adipose tissue of HF males when compared to their 
NC counterparts (Fig. 3.5A). Visceral white adipose tissue expression of adiponectin has been 
established to be higher in female compared to male rodents (Estrany, Proenza, Gianotti, and Lladó 
2013). We observed that adiponectin mRNA level was significantly higher in the perigonadal 
adipose tissue of HF female compared to HF male mice. However, no significant difference was 
detected in adiponectin mRNA levels of NC fed animals (Fig. 3.5B). Overall, the adipokine profile 
and the maintained response to metabolic stimuli in HF females may contribute to the preserved 
health of the local tissue. 
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3.6 Skeletal Muscle Vascular Content Maintained in HF-fed Male and Female Mice 
Differences in skeletal muscle sensitivity to in-vivo insulin may reflect changes in vascular 
content or function. In principle, a higher capillary content within skeletal muscle, through the 
process of angiogenesis, will increase the surface area for the flux of insulin and may enhance 
muscle perfusion of insulin. Conversely, vasodilation or outward remodeling of existing vessels, 
which both increase vessel circumference, can increase blood flow and total delivery of insulin to 
skeletal muscle. I first did a histological assessment of muscle fibers and capillaries to see whether 
sex differences exist in skeletal muscle capillary content (Fig. 3.6A). Capillary-to-fiber ratio (C:F) 
was used as an indicator of angiogenesis. C:F was not significantly different within the EDL 
muscle of NC- or HF-fed male and female mice (Fig. 3.6B). Also, no significant difference was 
detected in EDL muscle capillary density (Fig. 3.6C). Capillary density is influenced by the size 
of individual muscle fibers. Therefore, I measured muscle fiber cross-sectional area (um2) in the 
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EDL muscle and found no significant difference between NC- and HF-fed male and female mice 
(Fig. 3.6D). 
Next, I measured PECAM-1 mRNA level as a marker of endothelial cells within the EDL 
and TA muscles with the assumption that endothelial cell content would confirm the histological 
assessment of capillary number. HF diet significantly increased PECAM-1 mRNA level in the 
EDL muscle of HF females but not males, Furthermore, PECAM-1 expression was significantly 
higher in HF females vs. HF males (Fig. 3.6E). However, within the TA muscle, no significant 
differences were observed in PECAM-1 mRNA levels (Fig. 3.6F).  
Vascular Endothelial Growth Factor A (VEGF-A) and Thrombospondin-1 (THBS-1) are 
critical regulators of endothelial cell content and angiogenesis within skeletal muscle. VEGF-A 
promotes endothelial cell proliferation and capillary growth whereas THBS-1  has anti-angiogenic 
effects via promotion of endothelial cell apoptosis (Bornstein 2009; Ferrara, Gerber, and LeCouter 
2003a). VEGF-A mRNA expression was significantly higher in the TA muscle of NC female vs. 
NC male mice (Fig. 3.6G). However, no significant influence of sex was observed in VEGF-A 
mRNA levels of HF male and HF female mice. Also, no significant difference was found in THBS-
1 mRNA levels between NC- or HF-fed males and females (Fig. 3.6H). Leptin has been reported 
to have pro-angiogenic influences on endothelial cells (A Bouloumié et al. 1998; Sierra-
Honigmann et al. 1998)Leptin mRNA level was significantly higher within the TA muscle of HF 
male vs. NC male mice. Furthermore, there was a strong trend for HF females to have lower leptin 
expression compared to HF males (p=0.06) (Fig. 6I). Together, the expression pattern of 
angiogenic factors agreed with lack of change in capillary content within skeletal muscle. 
However, this would not explain why PECAM-1 mRNA level was different within the EDL 
muscle of HF-fed males and Females.   
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Endothelial cells are present in all vessels, including arterioles which contain smooth 
muscle cells. We hypothesized that increased PECAM1 mRNA may be associated with 
arteriolarization of capillaries or outward remodeling of existing arterioles. Both of these 
adaptations require the presence of more endothelial cells, however, this would not be reflected in 
muscle capillary number. We measured Myosin heavy chain 11 mRNA level as a marker of smooth 
muscle cells and indicator of arteriole content. However, no significant difference was found in 
MYH11 mRNA expression within the EDL muscle of HF-fed male and female mice (Fig. 3.6J). 
No conclusive results were found to indicate that the enhanced insulin responsiveness of 
skeletal muscle in females is related to adaptations in vessel content. Thus, we assessed the 
expression of factors that regulate vessel tone and may influence the delivery of insulin to skeletal 
muscle. Among them, eNOS (via production of NO) and endothelin (Edn-1) are two endothelium-
specific factors that induce vasodilation and vasoconstriction respectively. It has been previously 
shown that eNOS levels decrease and Edn-1 levels increase within the skeletal muscle of male rats 
fed a HF diet(Bourgoin et al. 2008). No significant influence of diet or sex was observed in the 
expression of eNOS mRNA within the TA muscles of the male and female mice (Fig. 3.7A). 
Measurement of phosphorylated eNOS (p-Ser473-eNOS) is a more accurate estimation of its 
enzymatic activity. I attempted to measure protein levels of p-eNOS relative to total eNOS by 
western blotting. The expected molecular weight for p-eNOS is 140 kDa. However, I was unable 
to detect bands at the correct molecular weight with antibodies currently available. No significant 
influence of diet was detected in Edn-1 mRNA levels, although there was a trend for higher Edn-
1expression in females compared to males (p=0.2 in NC, p=0.06 in HF groups) (Fig. 3.7B).  
We could not measure vasodilation or muscle blood flow directly, but we postulated that 
higher blood flow would increase the expression of genes activated by shear stress, the frictional 
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force of blood moving past the endothelial cell surface. We assessed the expression of shear-stress 
induced factors TGFβ, PDGFB, and KLF2 and found no significant differences in the expression 
of these factors, although a trend for higher KLF2 expression was present within the EDL muscle 
of HF female compared to HF male mice (Fig. 3.7C-E). Thus far, assessment of vessel content 
and function within the skeletal muscle of male and female mice shows inconclusive results and 
the role of vascular system in the maintained skeletal muscle response to insulin in HF females but 
not HF males remains to to be clarified.  
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3.7 Adipose Tissue Microvascular Content Maintained in HF Female Mice  
I also hypothesized that sex differences in adipose tissue sensitivity to metabolic stimuli 
may be related to differences in the vascular niche of male and female adipose tissue.  To examine 
this, I first established whether male and female adipose vascularization was different in response 
to HF feeding. Perigonadal white adipose tissue quantification of lectin staining as a percentage of 
field-of-view showed no significant difference in the adipose vascularization of NC male and NC 
female mice. In contrast, HF males had a significantly reduced, but HF females had a maintained, 
adipose vascular content (Fig. 3.8A, B). We observed that vessel branch point number per field-
of-view, which serves as an indicator of vessel sprout formation, was significantly higher in HF 
female vs. HF male mice. Furthermore, branch point number was significantly reduced only in 
male mice in response to the HF diet (Fig. 3.8C). This was further supported by higher mRNA 
levels of vascular marker PECAM-1 in HF females vs. HF males (Fig. 3.8D).  However, the mean 
diameter of capillaries within the adipose tissue of HF females was smaller compared to HF males 
(Fig. 3.8E, F).  
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3.8 Adipose Tissue Expression of Vascular Regulatory Factors  
To identify contributing factors in the sex-dependent regulation of visceral white adipose 
vascularization in response to a HF diet, I measured the expression of stimuli that influence 
vascular content and vascular tone. The mRNA expression of anti-angiogenic factor THBS-1 was 
not significantly different between NC male and NC female mice. However, THBS-1 mRNA level 
was significantly higher in HF female as compared to NC female and HF male mice (Fig. 3.9A). 
In response to a HF diet, VEGF-A mRNA level was significantly reduced in the perigonadal 
adipose of male but not female mice. Interestingly, under the normal condition of a NC diet, female 
mice had significantly lower VEGF-A mRNA level compared to males. However, this observation 
was reversed on a HF diet, where female mice had significantly higher VEGF-A expression vs. 
HF male mice (Fig. 3.9B). A trend similar to VEGF-A expression was also observed in the 
expression of eNOS and in the adipose tissue of female mice, eNOS mRNA level was significantly 
increased in response to the HF diet (Fig. 3.9C). I also measured expression of the vasoconstrictor 
factor EDN-1. However, no significant influence of sex or diet was detected in EDN-1 mRNA 
levels (Fig. 3.9D). 
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Chapter 4: Discussion 
 In this project, I have established that sex-related differences exist in microvascular 
adaptations in response to a HF diet. Following 16 weeks of HF feeding, I have shown that skeletal 
muscle and adipose tissue responsiveness to insulin is maintained in female mice but is severely 
impaired in male mice. Despite the indication of increased endothelial cell content within the 
skeletal muscle of HF females, no difference in capillary content was observed in either male and 
female mice. I report the novel finding that capillary content was significantly higher within the 
adipose tissue of HF female mice compared to HF male mice. Furthermore, HF female adipose 
tissue was characterized by an increase in the gene expression of adiponectin and pro-angiogenic 
factors. Altogether, these findings suggest that maintenance of tissue vasculature in HF female 
mice may be a contributing factor to a healthy tissue microenvironment and a maintained 
metabolic response.  
 
4.1 Sex Differences in Systemic Metabolic Functions 
 Marked sex differences have been established in the progression of metabolic disturbances 
in animals following HF feeding (Medrikova et al. 2012). When faced with the metabolic 
challenge of a HF diet, previous studies have shown males to be more prone to develop insulin 
resistance and weight gain compared to pre-menopausal females (El Akoum et al. 2011; Palmer 
and Clegg 2015; Shi et al. 2012). My findings confirmed that, following 16 weeks of HF feeding, 
female mice exhibit less weight gain and maintain systemic insulin sensitivity and glucose 
tolerance versus male mice, which develop impairments in both. To date, established mechanisms 
responsible for the sex-specific effects of a HF diet are unsettled. In both humans and animals, 
evidence of a strong link between visceral adiposity and insulin resistance suggests that the higher 
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distribution of visceral adipose tissue in males may predispose them to the development of 
metabolic dysfunction (Després and Lemieux 2006; Eliza B Geer and Shen 2009). Other studies 
examine the influence of sex hormones and speculate on the protective role of estrogen in insulin-
induced glucose uptake and cardiovascular function (Baker et al. 2003; Mauvais-Jarvis, Clegg, 
and Hevener 2013; Paranjape et al. 2005; Riant et al. 2109; Renee E Stubbins et al. 2012). Existing 
data also show that the lower production of pro-inflammatory cytokines and pro-inflammatory 
adipokines in females compared to males may protect against or delay the development of 
metabolic disturbances (Estrany et al. 2013; Mauvais-Jarvis et al. 2013). The majority of the 
aforementioned studies have examined a single tissue or systemic metabolism in general. This 
limits the conclusions that can be drawn considering that obesity-induced metabolic dysfunction 
is a systemic condition stemming from damage to multiple organs (Dimitriadis et al. 2011; Neto-
Ferreira et al. 2014). In this project, the combined analysis of skeletal muscle and adipose tissue 
aimed to better capture the underlying causes of sex differences in susceptibility to metabolic 
disruptions. 
 
4.2 Sex Differences in Tissue-specific Responses to Metabolic Stimuli and Adipokines 
HF diet-driven sex differences in systemic insulin sensitivity may be due to tissue-specific 
responses to insulin. Unlike their male counterparts, HF female mice exhibited a maintained 
skeletal muscle insulin responsiveness. This was evident as in vivo injection of insulin, which relies 
on the vascular delivery of insulin to muscle, induced a significant increase in phosphorylation of 
Akt within the skeletal muscle of HF females only. Conversely, HF males exhibited impaired 
impaired Akt phosphorylation in response to insulin, which confirms findings from other studies 
(van Haare et al. 2015; Senthil Kumar et al. 2014; White et al. 2014). HF diet-induced insulin 
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resistance could also involve impairments in adipose tissue insulin signaling and catecholamine-
induced lipolysis (Dimitriadis, Mitrou, Lambadiari, Maratou, and Sotirios A. Raptis 2011; Jocken 
et al. 2007; Mulder et al. 2003; Nagy, Levy, and Grunberger 1990; O’Carroll et al. 2013). I found 
that visceral adipose tissue responsiveness to insulin is maintained in female mice but impaired in 
male mice following HF feeding. This was evident as ex vivo insulin stimulation of adipose tissue 
induced a significant increase in phosphorylation of Akt in HF female mice but not HF male mice. 
This also is consistent with published data showing higher in vivo insulin-stimulated Akt activation  
in the adipose tissue of female mice compared to male mice on a HF diet (Senthil Kumar et al. 
2014).  
A blunted catecholamine-induced lipolysis response has previously been linked to a 
reduction in adipose tissue HSL mRNA and protein in insulin resistant obese individuals (Jocken 
et al. 2007). Furthermore, HSL- deficient mice develop impaired insulin sensitivity, which reveals 
the important role of this hormone in glucose handling (Fortier et al. 2005; Mulder et al. 2003). 
Building on these data, I established that sex differences exist in adipose tissue response to ex vivo 
isoproterenol stimulation, with significantly higher HSL phosphorylation in the visceral adipose 
of HF females compared to HF males (but no apparent differences in total HSL levels were 
observed). This raises the possibility that higher HSL activity in females may contribute to 
enhanced lipid mobilization and breakdown, whereas triglyceride accumulation and adipocyte 
expansion, associated with reduced HSL activity may subsequently impair insulin signaling in HF 
male mice.  
In HF female mice, maintained adipose tissue responsiveness to hormonal stimuli may be 
promoted by a healthier adipokine profile within the adipose microenvironment. It has previously 
been established that compared to males, females have higher circulating plasma levels of leptin 
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and adiponectin (Cnop et al. 2003; Hickey et al. 1996). I found no baseline differences in mRNA 
expression of leptin and adiponectin within the visceral adipose tissue of NC males and NC 
females. I measured mRNA expression of these adipokines within a section of visceral adipose as 
an indicator of the local environment of the tissue. Therefore, it may not match plasma levels of 
leptin and adiponectin which is the accumulation of adipokines released by total adipose tissue 
(both visceral and subcutaneous adipose depots). Multiple studies have linked higher leptin but 
lower adiponectin plasma levels to a state of reduced insulin sensitivity in obese rodents and 
humans, similar to the adipokine profile of our HF male (Kwon and Pessin 2013; Lihn et al. 2005; 
Weyer et al. 2001; Yadav et al. 2013). In contrast to this “obesogenic” adipokine profile, HF female 
mice had lower leptin but higher adiponectin mRNA expression within the visceral white adipose.  
Higher adiponectin levels in the visceral adipose tissue of HF female mice confirms 
previous data showing higher plasma adiponectin levels in HF-female mice associated with 
reduced tissue inflammation and a later onset of insulin resistance (Cnop et al. 2003; Medrikova 
et al. 2012). Montague et al. have reported that in female mice, leptin is predominantly released 
from subcutaneous adipose tissue (Montague et al. 1997). This may in turn account for the 
discrepancy between plasma and visceral adipose tissue leptin levels in females. Within the 
visceral adipose tissue of HF female mice, lower leptin (pro-inflammatory) but higher adiponectin 
(anti-inflammatory) levels may be associated with reduced inflammation and accumulation of 
immune cells, further contributing to a healthier tissue microenvironment (Kwon and Pessin 2013; 
Mancuso 2016; Ouchi et al. 2011). One key determinant of this phenotype is the tissue 
microvasculature, which controls the exchange of nutrients, oxygen and hormones (e.g. 
adipokines) as well as immune cells between the circulatory system and the surrounding tissue. 
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4.3 Capillary Content and Angiogenic factors in Skeletal Muscle  
 Within the microenvironment of skeletal muscle and adipose tissue, capillaries can be 
thought of as gate keepers that control the flux of hormones and nutrients from the circulatory 
system. Thus, capillaries serve as a key determinant of health and metabolic function of the local 
tissue. Skeletal muscle insulin sensitivity is strongly influenced by the microvasculature, which 
controls two critical factors: 1. insulin distribution through the capillary network (number of 
vessels/surface area); 2. regulation of insulin delivery to the muscle, which depends on blood flow 
and is modified by vascular tone (vasodilation or vasoconstriction of arterioles). Therefore, an 
increase in skeletal muscle vascularization or blood flow can facilitate insulin delivery and enhance 
insulin sensitivity of the tissue(Akerstrom et al. 2014; Kusters and Barrett 2016; Prior et al. 2015). 
I postulated that the maintained insulin sensitivity within skeletal muscle of HF female mice is a 
consequence of better tissue vascularization. The cellular actions of estrogen may enhance this 
phenotype in females since estrogen can promote VEGF-A expression, a dominant stimulator of 
angiogenesis, and induce proliferation and migration of mature progenitor endothelial cells 
(Bausero et al. 2000; Liang, Han, and Chen 2013; Minokoshi et al. 2002; Strehlow et al. 2003; 
Zhao et al. 2008). However, I did not detect a significant difference in capillary content of male 
and female EDL muscle. This indicates that vasculoprotective effects of estrogen on endothelial 
cells may not affect capillary number within skeletal muscle of female mice. Furthermore, I 
confirmed that HF feeding does not alter capillary number within skeletal muscle of either male 
or female mice. To my knowledge, HF diet-induced alterations in skeletal muscle angiogenesis 
have been studied in only a few experiments, which investigated only male rodents. These studies 
show conflicting results ranging from improvements to impairments in capillary content. 
Silvennoinen et al. reported that 19 weeks of HF diet induces angiogenesis and increases capillary 
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content within skeletal muscle of male mice (2013). On the contrary, HF diet has been reported to 
impair skeletal muscle angiogenesis after ischemia-induced capillary rarefaction (Li et al. 2007). 
Also, Roudier et al. found no significant difference in capillary content between NC and HF rats 
(2009). In a recent study, our lab also observed no significant difference in capillary content of 
male mice fed a NC- or HF- diet for 16 weeks (Nwadozi).  
Regulation of capillary number is mediated by the expression of pro-angiogenenic and anti-
angiogenic factors (Gustafsson 2011). VEGF-A is a predominant stimulator of angiogenesis and 
THBS-1 is a potent inhibitor of angiogenesis (Bornstein 2009; Gustafsson 2011; Haas 2002). I 
found that neither sex nor diet influenced VEGF-A and THBS-1 mRNA levels within the EDL 
muscle. This closely matched with the unchanged capillary content within the EDL muscle of male 
and and female mice. Maintained expression of angiogenic stimulators and inhibitors may be 
attributed to lack of a strong stimulation by the HF diet (either due to diet duration or fat content). 
Silvennoinen et al. reported increased VEGF-A protein levels in quadriceps femoris muscle of 
male mice following 19 weeks of HF feeding, using a HF diet (60% fat) as we have used but for a 
longer duration (2013). On the other hand, the long-term duration of a diet may mask the initial 
anti- angiogenic responses such as changes in the expression of THBS-1. In male mice, THBS-1 
levels has been shown to increase in early stages of HF feeding (first 3 weeks) (Inoue et al. 2013). 
Furthermore, I looked at leptin expression because it is elevated in obesity and has a pro-
angiogenic influence by promoting endothelial cell activation, proliferation and survival (Anne 
Bouloumié et al. 1998; Kurtovic et al. 2015; Scarpace and Zhang 2007; Sierra-Honigmann et al. 
1998). Thus, leptin may be a relevant angiogenic regulator in the context of HF-diet induced 
obesity. No significant influence of sex was observed in muscle mRNA expression of leptin. 
However, HF feeding significantly increased leptin mRNA expression within the skeletal muscle 
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of male mice. Since adipocytes are the main source of leptin, this may be due to higher 
intramuscular adipose within skeletal muscle of HF males as others have observed increased 
intramuscular adipose and lipid accumulation in obese and insulin resistant individuals (Pan et al. 
1997; Stump et al. 2006b).  
PECAM-1 is localized on the endothelial cell junctions and its expression in skeletal 
muscle has been used as indicator of endothelial cell number and capillary content (DeLisser et al. 
1994; Roudier et al. 2009). The higher PECAM-1 mRNA expression in HF female mice suggests 
that more endothelial cells are present within skeletal muscle of HF female compared to HF male 
mice. Although this is consistent with the reported proliferative effects of estrogen on endothelial 
cells (Oviedo et al. 2011), it is inconsistent with the lack of change in capillary number in female 
mice. Endothelial cells also are a major component of arterioles and changes in PECAM-1 could 
reflect altered arteriole structure or number. I then turned my attention to structural adaptations 
that may occur in the arterioles of female mice, resulting in higher number of endothelial cells. 
 
4.4 Arteriole Remodeling and Vasodilator Stimuli in Skeletal Muscle 
Estrogen can bind to receptors on the surface of endothelial cells and, via PI3k-Akt 
activation of eNOS, induce NO-dependent vasodilation (Haynes et al. 2000). This increases blood 
flow which serves as a stimulus for outward remodeling of arterioles or arteriolarization of existing 
capillaries (Korshunov et al. 2007; Renna et al. 2013). These  adaptations may in turn enhance 
delivery of insulin (due to a wider vessel lumen) and contribute to the maintained insulin 
responsiveness in HF females compared to HF males. Outward remodeling of arterioles or 
arteriolarization both require higher endothelial cell content, as observed in HF females, and  
higher smooth muscle cell content (Baum et al. 2005; Renna et al. 2013). However, MYH11 (a 
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marker of smooth muscle cell content) mRNA expression was not significantly different between 
HF male and HF female mice, which does not support the assumption that structural modifications 
in muscle arterioles may account for the observed sex differences in muscle sensitivity to in-vivo 
insulin.  
I then hypothesized that maintained insulin sensitivity in HF female muscle may occur as 
a result of estrogen induced vasodilation and enhanced delivery of insulin, which could occur 
independent of changes in capillary or arteriole content. I could not measure blood flow and 
vascular tone directly in the current experiment. Therefore, mRNA expression of eNOS and Edn-
1, which are dominant regulators of vessel tone, was measured. However, no significant influence 
of sex or diet was observed, which suggests that a vasodilation-vasocontraction balance may be 
maintained within skeletal muscle of NC- and HF-fed male and female mice. Measurement of 
eNOS and Edn-1 at the mRNA level may not capture sex or diet-induced differences in the 
expression of these factors. In contrast to my results, which assessed mRNA levels, previous 
studies have shown that both diet and sex hormones can influence protein expression and activity 
of eNOS and Edn-1. It has been reported that HF diet decreases eNOS activity associated with 
impairments in endothelium dependent dilation of arterioles within skeletal muscle of male rats 
(Erdei et al. 2006). Furthermore, administration of estrogen has been shown to decrease endothelial 
cell production of Edn-1 while testosterone can increase edn-1 levels (Akishita et al. 1998; 
Polderman et al. 1993). Edn-1 is transcribed as a prepro-endothelin1 peptide which must get 
cleaved at multiple sites for an active end product, therefore its final protein levels may be 
substantially different from mRNA levels.  
Vascular endothelial cells are constantly exposed to shear stress (mechanical force of blood 
flow on the endothelium) which stimulates expression of genes involved in capillary remodeling. 
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In this study, expression of three shear-stress induced genes (TGFβ, PDGFβ, and KLF2) was also 
used as an indirect measurement of blood flow (Walshe et al. 2013). Considering that an increase 
in the expression of these genes would be associated with higher flow, we can infer that delivery 
of insulin would also be higher which may account for a higher muscle insulin response in HF 
females compared to HF males. However, the lack of a significant difference in the expression of 
TGFβ, PDGFβ, and KLF2 mRNA between HF male and HF female mice did not provide evidence 
that flow and delivery of insulin is sexually dimorphic. Although, the possibility that shear stress 
may influence regulation of other genes in a sex-dependent manner cannot be excluded.  
To gain a better understanding if sex differences exist in the regulation of other shear stress 
induced genes, in vitro endothelial cell culture experiments examining the direct influence of shear 
stress on male and female vasculature can be conducted using a parallel plate flow system 
(Milkiewicz et al. 2011). Altogether, data obtained from the skeletal muscle of male and female 
mice does not provide conclusive evidence of the influence of sex or diet on structural adaptations 
in muscle capillaries or arterioles. Moreover, indirect measurements of blood flow and stimuli 
involved in the regulation of vessel tone does not support the assumption that insulin delivery to 
muscle may be different between male and female mice as a result of vasculoprotective effects of 
estrogen. Therefore, the vascular influence on the maintained insulin response of HF female 
skeletal muscle, but the impaired response in HF male mice, remains to be established. 
 
4.5 Capillary Content and Angiogenic Factors in Visceral Adipose Tissue 
Maintained capillary content in the visceral adipose tissue of HF females but not HF male 
mice provides novel evidence that sex differences exist in adipose tissue capillary adaptations to a 
high-fat diet. This was detected by lectin staining and confirmed by adipose PECAM-1 mRNA 
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levels. Accordingly, a lower number of vessel sprouts (branch points) is indicative of capillary 
rarefaction within adipose tissue of HF male mice. This is consistent with previous data  showing 
lower capillary content within adipose tissue of obese individuals and HF fed male rodents 
(Michailidou et al. 2012; Pasarica et al. 2009; Spencer et al. 2011). The process of angiogenesis is 
an integral component of adipose tissue expansion since growth of adipocytes requires a 
concomitant increase in gas and substrate exchange (Cao 2013; Rupnick et al. 2002; Sun, 
Kusminski, and Scherer 2011). A healthy adipose tissue expansion requires coordinated paracrine 
signaling between adipocytes and endothelial cells to maintain adequate vascularization. I 
postulate that a maintained capillary content within adipose tissue of HF females preserves this 
cross-talk, which can contribute to a maintained insulin response. In contrast, capillary regression 
in the adipose of HF males limits distribution of oxygen, hormones, and nutrients. Consecutively, 
this can be associated with profound changes within adipose tissue microenvironment including 
local hypoxia, inflammatory cell infiltration, oxidative damage, and fibrosis, all of which can 
compromise tissue function and response to metabolic stimuli such as insulin (Michailidou et al. 
2012; Sun et al. 2011). 
 A maintained capillary content within adipose tissue of HF females compared to HF males 
may in part be due to the pro-angiogenic influence of estrogen on VEGF-A and leptin expression. 
I found that in response to the HF diet, VEGF-A and leptin mRNA levels were maintained within 
the adipose tissue of female mice. As mentioned earlier, estrogen can stimulate VEGF-A gene 
expression and induce proliferation of endothelial cells (Bausero et al. 2000). Furthermore, studies 
show that following ovariectomy, serum leptin levels and expression of the leptin (ob) gene in 
white adipose tissue is significantly decreased; meanwhile, this can be reversed by estrogen 
hormone therapy in both women and rodent models (Messinis et al. 1999; Shimizu et al. 1997; 
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Yoneda et al. 1998). Therefore, estrogen can maintain leptin levels and preserve its pro-angiogenic 
role in endothelial cell proliferation and survival (Anne Bouloumié et al. 1998; Sierra-Honigmann 
et al. 1998). In HF male mice, lower capillary density is paralleled by a lower mRNA expression 
of the dominant pro-angiogenic factor VEGF-A. This is consistent with data showing that the 
induced deletion of VEGF-A decreases adipose tissue vascularization, whereas its over-expression 
in HF-fed male mice enhances vascular density (Sun et al. 2011; Sung et al. 2013). Increases in 
pro-angiogenic factor leptin mRNA did not rescue HF male adipose from capillary regression. 
This may be due to HF- diet induced upregulation of anti-angiogeneic factors which may negate 
the pro-angiogenic influence of leptin. However, I found that THBS-1 expression within the HF 
male adipose was not higher. There is a possibility that endothelial cells may have become resistant 
to leptin (Hsuchou et al. 2013; Mark et al. 2002), which is another indication of the loss of cross-
talk between endothelial cells and adipocytes in HF male mice. 
 Higher adiponectin expression may also contribute to the maintenance of adipose capillary 
content in HF female mice, considering that adiponectin has a pro-angiogenic role in 
differentiation and migration of endothelial cells into capillary-like structures (Maeda et al. 2002). 
Studies have shown that adiponectin-deficient mice develop insulin resistance in response to both 
NC and HF diets (Kubota et al. 2002; Maeda et al. 2002). Furthermore, Adiponectin-KO mice 
exhibit impaired endothelium-dependent vasodilation  associated with endothelial cell dysfunction 
(Ouchi et al. 2003). Collectively, this suggests that a significant reduction in adiponectin 
expression, as occurred in the adipose of our HF males, may participate in loss of tissue capillaries 
and induce deficits in adipose tissue response to insulin. Finally, higher expression of eNOS within 
the adipose tissue of HF female mice may be indicative of higher NO bioavailability and NO-
induced vasodilation. As a result, increased blood flow and oxygen delivery helps preserve 
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vascularization and maintain a healthy adipose tissue environment in HF female mice. Altogether, 
data obtained from analysis of the adipose tissue capillary content imply that tissue release of 
adiponectin and pro- angiogenic factors help maintain the vascular niche within the adipose of HF 
female mice, whereas the metabolic stress of a HF diet induces capillary regression in adipose 
tissue of males. This established difference may in turn contribute to sex differences in the adipose 
tissue response to metabolic stimuli and ultimately influence whole body metabolic functions such 
as glucose homeostasis.  
 
4.6 Summary 
In this project I confirmed that whole-body, as well as skeletal muscle and adipose tissue, 
response to insulin is maintained in HF females but not HF male mice. In skeletal muscle, this was 
accompanied by higher PECAM-1 expression in HF female mice (EC content), although no 
significant difference in capillary and arteriole distribution or function was established. This leaves 
the underlying signaling mechanisms responsible for sex differences in skeletal muscle response 
to insulin open to be explored. Maintenance of adipose tissue capillary content in HF females was 
paralleled by a maintained adipose response to metabolic stimuli and a healthy adipokine profile. 
This highlights the important role of the capillaries in the regulation and maintenance of a healthy 
microenvironment within adipose tissue, which may contribute to sex-differences in the 
development of metabolic disorders. 
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Chapter 5: Conclusion 
5.1 Significance 
My master’s thesis provides novel evidence that sex differences in vascular content exist 
in response to the metabolic stress of a HF diet. This study, along with others in humans and animal 
models, demonstrates lower susceptibility of females to the development of diet-induced metabolic 
dysfunctions (insulin resistance and glucose intolerance) as compared to male mice (Frias et al. 
2001; Krotkiewski et al. 1983; Medrikova et al. 2012; Priego et al. 2008). To date, studies 
investigating sex-associated differences in obesity have predominantly focused on tissue 
metabolism and fat distribution, while the microvascular contribution to these differences has been 
overlooked. To fill this knowledge gap, I had the unique opportunity to examine vascular 
adaptations in two metabolically active tissues (skeletal muscle and adipose tissue), as a possible 
underlying cause of sex differences in HF-diet induced metabolic dysregulations. This project is a 
starting point to establish that sex differences in angiogenic responses to a HF diet exist. This 
provides a glimpse into the identification of novel sex-hormone-dependent pathways that regulate 
angiogenesis, in addition to providing significant insight into the possible link between capillary 
content and development of insulin resistance. Collectively, findings from this project highlight 
the possible associations that may exist between metabolic and vascular parameters and provides 
the opportunity to explore essential signaling pathways that regulate capillary content within the 
context of diet-induced obesity.  
5.2 Limitations 
 A limitation of this study is that none of the angiogenic factors or adipokines were 
measured at protein level. Level of mRNA could be altered by post-transcriptional modifications 
and differ from final protein levels. To gain a better representation of the angiogenic and adipokine 
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profile of male and female mice, measurement of these factors at protein level is necessary. 
However, available antibodies for some of these factors, particularly VEGF-A and eNOS are not 
accurate. The use of an in-vivo insulin stimulation model enabled me to examine the influence of 
vascular delivery of insulin to skeletal muscle. A recognized limitation of this analysis is that it 
does not exclude myocyte response to insulin which may contribute to the observed differences. 
However, our lab has recently observed that in HF male mice, Akt phosphorylation in muscle 
incubated with insulin ex-vivo (where insulin delivery is not dependent on the vasculature) is not 
impaired in HF male mice when compared to their NC-fed counterparts (unpublished data). 
Female tissue was collected irrespective of the ovarian cycle. Considering the role estrogen has in 
transcription of angiogenic factors such as VEGF-A and insulin signaling pathways, differences 
in estrous cycle of mice at the time of tissue collection may have introduced variability in the 
results and masked the true extent of statistical significance when compared to male mice (Bausero 
et al. 2000; Fuente-Martín et al. 2013; Liang et al. 2013). Furthermore, I did not have a direct 
measurement of blood flow to examine vessel tone and insulin delivery within adipose tissue and 
skeletal muscle. This can be addressed in future studies by injection of microspheres into the 
circulation and measurement of blood flow in tissue relative to tissue mass. 
 
5.3 Future Directions 
Two mechanisms may be responsible for sex differences in adipose tissue capillary number 
in the context of HF diet-induced obesity: 1. Steroid sex hormones directly influence regulation of 
capillary number within adipose tissue (Ajayi, Ogungbade, and Okorodudu 2004; Liu et al. 2002; 
Losordo and Isner 2001); 2. HF-diet induced changes in sex chromosome gene expression 
contribute to changes in the expression of angiogenic factors and alter capillary number in a sex-
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dependent manner (Link et al. 2013; Lorenz et al. 2015). While it is appreciated that estrogen 
influences vascular functions and has a protective role in the development of metabolic 
dysfunctions (Riant et al. 2109), the influence of estrogen and testosterone hormone on the 
angiogenic regulation of adipose tissue is not established yet. A follow-up project to my Master’s 
thesis project can be to elucidate sex-hormone dependent regulation of capillary number within 
adipose tissue. This can be accomplished by surgical removal of gonads (gonadectomy) in male 
and female mice. Both male and female mice can then undergo hormone therapy by injection of 
estrogen or testosterone while fed a NC or HF diet to see if switch to the opposite sex hormone, 
while keeping the genetic environment constant, can alter capillary number and angiogenic 
regulation within the adipose tissue.  
Recently, our group has reported the anti-angiogenic influence of FoxO1 transcription 
factors in HF diet-induced capillary regression within skeletal muscle of male mice (Nwadozi et 
al. 2016). Measurement of FoxO1 in male and female adipose tissue may help identify if sex-
dependent differences in upregulation of FoxO1 accounts for capillary regression in adipose tissue 
of males, as compared to females which may be protected from this angiogenic influence. If sex 
differences in FoxO1 levels do exist, we can then examine if sex hormones modify the expression 
of FoxO1 using cultured murine endothelial cells. Collectively, these experiments can help 
establish if steroid sex hormones contribute to differences in adipose tissue capillary content in 
male and female mice faced with the metabolic challenge of a HF diet. Furthermore, they can help 
gain a better understanding of the microvascular contribution to metabolic dysfunction in the 
context of HF diet-induced obesity. 
 
 
 
 
 72 
References 
 
Ahmadian, Maryam, Robin E. Duncan, Kathy Jaworski, Eszter Sarkadi-Nagy, and Hei Sook Sul. 
2007. “Triacylglycerol Metabolism in Adipose Tissue.” Future lipidology 2(2):229–37. 
Ajayi, A. A., G. O. Ogungbade, and A. O. Okorodudu. 2004. “Sex Hormone Regulation of 
Systemic Endothelial and Renal Microvascular Reactivity in Type-2 Diabetes: Studies in 
Gonadectomized and Sham-Operated Zucker Diabetic Rats.” European journal of clinical 
investigation 34(5):349–57. 
Akerstrom, T. et al. 2014. “Increased Skeletal Muscle Capillarization Enhances Insulin 
Sensitivity.” AJP: Endocrinology and Metabolism 307(12):E1105–16. 
Akishita, Masahiro et al. 1998. “Estrogen Attenuates Endothelin-1 Production by Bovine 
Endothelial Cells via Estrogen Receptor.” Biochemical and Biophysical Research 
Communications 251(1):17–21. 
El Akoum, Souhad, Vikie Lamontagne, Isabelle Cloutier, and Jean-François Tanguay. 2011. 
“Nature of Fatty Acids in High Fat Diets Differentially Delineates Obesity-Linked 
Metabolic Syndrome Components in Male and Female C57BL/6J Mice.” Diabetology & 
Metabolic Syndrome 3(1):34. 
Aprahamian, Tamar R. 2013. “Elevated Adiponectin Expression Promotes Adipose Tissue 
Vascularity under Conditions of Diet-Induced Obesity.” Metabolism: clinical and 
experimental 62(12):1730–38. 
Arenas, Ivan A., Stephen J. Armstrong, Yi Xu, and Sandra T. Davidge. 2005. “Chronic Tumor 
Necrosis Factor-α Inhibition Enhances NO Modulation of Vascular Function in Estrogen-
Deficient Rats.” Hypertension 46(1). 
Arnet, U. A., A. McMillan, J. L. Dinerman, B. Ballermann, and C. J. Lowenstein. 1996. 
“Regulation of Endothelial Nitric-Oxide Synthase during Hypoxia.” The Journal of 
biological chemistry 271(25):15069–73. 
Baker, Lauren et al. 2003. “The Role of Estrogen in Cardiovascular Disease.” The Journal of 
surgical research 115(2):325–44. 
Barrett, E. J. et al. 2009. “The Vascular Actions of Insulin Control Its Delivery to Muscle and 
Regulate the Rate-Limiting Step in Skeletal Muscle Insulin Action.” Diabetologia 
52(5):752–64. 
Baum, Oliver et al. 2004. “Endothelial NOS Is Main Mediator for Shear Stress-Dependent 
Angiogenesis in Skeletal Muscle after Prazosin Administration.” American Journal of 
Physiology - Heart and Circulatory Physiology 287(5). 
Baum, Oliver, Valentin Djonov, Murielle Ganster, Matthias Widmer, and Iris Baumgartner. 
2005. “Arteriolization of Capillaries and FGF-2 Upregulation in Skeletal Muscles of 
Patients with Chronic Peripheral Arterial Disease.” Microcirculation 12(6):527–37. 
Bausero, P., M. Ben-Mahdi, J. Mazucatelli, C. Bloy, and M. Perrot-Applanat. 2000. “Vascular 
Endothelial Growth Factor Is Modulated in Vascular Muscle Cells by Estradiol, Tamoxifen, 
and Hypoxia.” American journal of physiology. Heart and circulatory physiology 
279(5):H2033-42. 
Beigh, Seerat Hussain and Saroj Jain. 2012. “Prevalence of Metabolic Syndrome and Gender 
Differences.” Bioinformation 8(13):613–16. 
Benz, Verena et al. 2012. “Sexual Dimorphic Regulation of Body Weight Dynamics and 
Adipose Tissue Lipolysis” edited by I. A. Dahlman. PLoS ONE 7(5):e37794. 
Bernatchez, P. N., S. Soker, and M. G. Sirois. 1999. “Vascular Endothelial Growth Factor Effect 
 73 
on Endothelial Cell Proliferation, Migration, and Platelet-Activating Factor Synthesis Is 
Flk-1-Dependent.” The Journal of biological chemistry 274(43):31047–54. 
Björntorp, P. et al. 1997. “Body Fat Distribution, Insulin Resistance, and Metabolic Diseases.” 
Nutrition (Burbank, Los Angeles County, Calif.) 13(9):795–803. 
BOHM, F. and J. PERNOW. 2007. “The Importance of Endothelin-1 for Vascular Dysfunction 
in Cardiovascular Disease.” Cardiovascular Research 76(1):8–18. 
Bonner, Jeffrey S. et al. 2013. “Muscle-Specific Vascular Endothelial Growth Factor Deletion 
Induces Muscle Capillary Rarefaction Creating Muscle Insulin Resistance.” Diabetes 62(2). 
Bornstein, Paul. 2009. “Thrombospondins Function as Regulators of Angiogenesis.” Journal of 
cell communication and signaling 3(3–4):189–200. 
Bouloumié, A., H. C. Drexler, M. Lafontan, and R. Busse. 1998. “Leptin, the Product of Ob 
Gene, Promotes Angiogenesis.” Circulation research 83(10):1059–66. 
Bouloumie, A., T. Marumo, M. Lafontan, and R. Busse. 1999. “Leptin Induces Oxidative Stress 
in Human Endothelial Cells.” FASEB J 13(10):1231–38. 
Bouloumié, Anne, Hannes C. A. Drexler, Max Lafontan, and Rudi Busse. 1998. “Leptin, the 
Product of Ob Gene, Promotes Angiogenesis.” Circulation Research 83(10). 
Bourgoin, Frédéric et al. 2008. “Endothelial and Vascular Dysfunctions and Insulin Resistance in 
Rats Fed a High-Fat, High-Sucrose Diet.” American Journal of Physiology - Heart and 
Circulatory Physiology 295(3). 
Bourque, S. L., S. T. Davidge, and M. A. Adams. 2011. “The Interaction between Endothelin-1 
and Nitric Oxide in the Vasculature: New Perspectives.” AJP: Regulatory, Integrative and 
Comparative Physiology 300(6):R1288–95. 
Brown, L. M. et al. 1997. “Role of the Matrixin MMP-2 in Multicellular Organization of 
Adipocytes Cultured in Basement Membrane Components.” American Journal of 
Physiology - Cell Physiology 272(3). 
Bruns, R. R. and G. E. Palade. 1968. “Studies on Blood Capillaries. I. General Organization of 
Blood Capillaries in Muscle.” The Journal of cell biology 37(2):244–76. 
Caduff, J. H., L. C. Fischer, and P. H. Burri. 1986. “Scanning Electron Microscope Study of the 
Developing Microvasculature in the Postnatal Rat Lung.” The Anatomical Record 
216(2):154–64. 
Cao, R., E. Brakenhielm, C. Wahlestedt, J. Thyberg, and Y. Cao. 2001. “Leptin Induces Vascular 
Permeability and Synergistically Stimulates Angiogenesis with FGF-2 and VEGF.” 
Proceedings of the National Academy of Sciences of the United States of America 
98(11):6390–95. 
Cao, Yihai. 2007. “Angiogenesis Modulates Adipogenesis and Obesity.” The Journal of clinical 
investigation 117(9):2362–68. 
Cao, Yihai. 2013. “Angiogenesis and Vascular Functions in Modulation of Obesity, Adipose 
Metabolism, and Insulin Sensitivity.” Cell Metabolism 18(4):478–89. 
Carmeliet, Peter et al. 1996. “Abnormal Blood Vessel Development and Lethality in Embryos 
Lacking a Single VEGF Allele.” Nature 380(6573):435–39. 
Catalano, D. et al. 2008. “Insulin Resistance in Postmenopausal Women: Concurrent Effects of 
Hormone Replacement Therapy and Coffee.” Climacteric 11(5):373–82. 
Cheatham, B. et al. 1994. “Phosphatidylinositol 3-Kinase Activation Is Required for Insulin 
Stimulation of pp70 S6 Kinase, DNA Synthesis, and Glucose Transporter Translocation.” 
Molecular and cellular biology 14(7):4902–11. 
Chien, Shu. 2007. “Mechanotransduction and Endothelial Cell Homeostasis: The Wisdom of the 
 74 
Cell.” American Journal of Physiology - Heart and Circulatory Physiology 292(3). 
Cnop, M. et al. 2003. “Relationship of Adiponectin to Body Fat Distribution, Insulin Sensitivity 
and Plasma Lipoproteins: Evidence for Independent Roles of Age and Sex.” Diabetologia 
46(4):459–69. 
Corvera, Silvia and Olga Gealekman. 2014. “Adipose Tissue Angiogenesis: Impact on Obesity 
and Type-2 Diabetes.” Biochimica et biophysica acta 1842(3):463–72. 
Crawford, S. E. et al. 1998. “Thrombospondin-1 Is a Major Activator of TGF-beta1 in Vivo.” 
Cell 93(7):1159–70. 
Dai, Xuming and James E. Faber. 2010. “Endothelial Nitric Oxide Synthase Deficiency Causes 
Collateral Vessel Rarefaction and Impairs Activation of a Cell Cycle Gene Network during 
Arteriogenesis.” Circulation research 106(12):1870–81. 
Davis, Michael E., Hua Cai, Grant R. Drummond, and David G. Harrison. n.d. “Shear Stress 
Regulates Endothelial Nitric Oxide Synthase Expression Through c-Src by Divergent 
Signaling Pathways.” 
Dekker, Rob J. et al. 2002. “Prolonged Fluid Shear Stress Induces a Distinct Set of Endothelial 
Cell Genes, Most Specifically Lung Krüppel-like Factor (KLF2).” Blood 100(5). 
DeLisser, Horace M., Peter J. Newman, and Steven M. Albelda. 1994. “Molecular and 
Functional Aspects of PECAM-1/CD31.” Immunology Today 15(10):490–95. 
Després, Jean-Pierre and Isabelle Lemieux. 2006. “Abdominal Obesity and Metabolic 
Syndrome.” Nature 444(7121):881–87. 
Dimitriadis, George, Panayota Mitrou, Vaia Lambadiari, Eirini Maratou, and Sotirios A. Raptis. 
2011. “Insulin Effects in Muscle and Adipose Tissue.” Diabetes Research and Clinical 
Practice 93:S52–59. 
Dimitriadis, George, Panayota Mitrou, Vaia Lambadiari, Eirini Maratou, and Sotirios A. Raptis. 
2011. “Insulin Effects in Muscle and Adipose Tissue.” Diabetes Research and Clinical 
Practice 93:S52–59. 
Duffy, Angela M., David J. Bouchier-Hayes, and Judith H. Harmey. 2013. “Vascular Endothelial 
Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by 
VEGF.” 
Egginton, S. et al. 1998. “Capillary Growth in Relation to Blood Flow and Performance in 
Overloaded Rat Skeletal Muscle.” Journal of applied physiology (Bethesda, Md. : 1985) 
85(6):2025–32. 
Egginton, S. 2011. “Physiological Factors Influencing Capillary Growth.” Acta physiologica 
(Oxford, England) 202(3):225–39. 
Ellsworth, M. L. and R. N. Pittman. 1990. “Arterioles Supply Oxygen to Capillaries by Diffusion 
as Well as by Convection.” American Journal of Physiology - Heart and Circulatory 
Physiology 258(4). 
Epstein, Franklin H., Salvador Moncada, and Annie Higgs. 1993. “The L-Arginine-Nitric Oxide 
Pathway.” New England Journal of Medicine 329(27):2002–12. 
Erdei, Nóra et al. 2006. “High-Fat Diet-Induced Reduction in Nitric Oxide-Dependent Arteriolar 
Dilation in Rats: Role of Xanthine Oxidase-Derived Superoxide Anion.” American Journal 
of Physiology - Heart and Circulatory Physiology 291(5). 
Estrany, Maria E., Ana M. Proenza, Magdalena Gianotti, and Isabel Llad? 2013. “High-Fat Diet 
Feeding Induces Sex-Dependent Changes in Inflammatory and Insulin Sensitivity Profiles 
of Rat Adipose Tissue.” Cell Biochemistry and Function 31(6):504–10. 
Estrany, Maria E., Ana M. Proenza, Magdalena Gianotti, and Isabel Lladó. 2013. “High-Fat Diet 
 75 
Feeding Induces Sex-Dependent Changes in Inflammatory and Insulin Sensitivity Profiles 
of Rat Adipose Tissue.” Cell Biochemistry and Function 31(6):504–10. 
Ferrara, Napoleone, Hans-Peter Gerber, and Jennifer LeCouter. 2003a. “The Biology of VEGF 
and Its Receptors.” Nature Medicine 9(6):669–76. 
Ferrara, Napoleone, Hans-Peter Gerber, and Jennifer LeCouter. 2003b. “The Biology of VEGF 
and Its Receptors.” Nature medicine 9(6):669–76. 
Ferrara, Napoleone and William J. Henzel. 1989. “Pituitary Follicular Cells Secrete a Novel 
Heparin-Binding Growth Factor Specific for Vascular Endothelial Cells.” Biochemical and 
Biophysical Research Communications 161(2):851–58. 
Flier, Jeffrey S., Lisa H. Underhill, and Judah Folkman. 1995. “Clinical Applications of 
Research on Angiogenesis.” New England Journal of Medicine 333(26):1757–63. 
Flück, M. and H. Hoppeler. 2003. “Molecular Basis of Skeletal Muscle Plasticity-from Gene to 
Form and Function.” Pp. 159–216 in Reviews of Physiology, Biochemistry and 
Pharmacology. Berlin, Heidelberg: Springer Berlin Heidelberg. 
Fortier, Mélanie et al. 2005. “Human Hormone-Sensitive Lipase (HSL): Expression in White Fat 
Corrects the White Adipose Phenotype of HSL-Deficient Mice.” Journal of lipid research 
46(9):1860–67. 
Frias, J. P. et al. 2001. “Decreased Susceptibility to Fatty Acid-Induced Peripheral Tissue Insulin 
Resistance in Women.” Diabetes 50(6):1344–50. 
Fridlyand, L. E. and L. H. Philipson. 2006. “Reactive Species and Early Manifestation of Insulin 
Resistance in Type 2 Diabetes.” Diabetes, Obesity and Metabolism 8(2):136–45. 
Frisbee, J. C., J. B. Samora, J. Peterson, and R. Bryner. 2006. “Exercise Training Blunts 
Microvascular Rarefaction in the Metabolic Syndrome.” AJP: Heart and Circulatory 
Physiology 291(5):H2483–92. 
Frisbee, Jefferson C. 2003. “Remodeling of the Skeletal Muscle Microcirculation Increases 
Resistance to Perfusion in Obese Zucker Rats.” American Journal of Physiology - Heart 
and Circulatory Physiology 285(1):H104–11. 
Fuente-Martín, Esther, Pilar Argente-Arizón, Purificación Ros, Jesús Argente, and Julie A. 
Chowen. 2013. “Sex Differences in Adipose Tissue: It Is Not Only a Question of Quantity 
and Distribution.” Adipocyte 2(3):128–34. 
Fukumura, Dai et al. 2003. “Paracrine Regulation of Angiogenesis and Adipocyte Differentiation 
during in Vivo Adipogenesis.” Circulation research 93(9):e88-97. 
Fulton, D. et al. 1999. “Regulation of Endothelium-Derived Nitric Oxide Production by the 
Protein Kinase Akt.” Nature 399(6736):597–601. 
Gavin, Timothy P. et al. 2004. “Lower Capillary Density but No Difference in VEGF Expression 
in Obese Vs.lean Young Skeletal Muscle in Humans.” Journal of Applied Physiology 
Version of Record Available @ 315–21. 
Gealekman, Olga et al. 2011. “Depot-Specific Differences and Insufficient Subcutaneous 
Adipose Tissue Angiogenesis in Human ObesityClinical Perspective.” Circulation 123(2). 
Gee, Eric, Malgorzata Milkiewicz, and Tara L. Haas. 2010. “p38 MAPK Activity Is Stimulated 
by Vascular Endothelial Growth Factor Receptor 2 Activation and Is Essential for Shear 
Stress-Induced Angiogenesis.” Journal of Cellular Physiology 222(1):120–26. 
Geer, Eliza B. and Wei Shen. 2009. “Gender Differences in Insulin Resistance, Body 
Composition, and Energy Balance.” Gender Medicine 6:60–75. 
Geer, Eliza B. and Wei Shen. 2009. “Gender Differences in Insulin Resistance, Body 
Composition, and Energy Balance.” Gender medicine 6 Suppl 1(Suppl 1):60–75. 
 76 
Gerhardt, Holger et al. 2003. “VEGF Guides Angiogenic Sprouting Utilizing Endothelial Tip 
Cell Filopodia.” Journal of Cell Biology 161(6):1163–77. 
Good, D. J. et al. 1990. “A Tumor Suppressor-Dependent Inhibitor of Angiogenesis Is 
Immunologically and Functionally Indistinguishable from a Fragment of Thrombospondin.” 
Proceedings of the National Academy of Sciences of the United States of America 
87(17):6624–28. 
Goodwill, Adam G. and Jefferson C. Frisbee. 2012. “Oxidant Stress and Skeletal Muscle 
Microvasculopathy in the Metabolic Syndrome.” Vascular pharmacology 57(5–6):150–59. 
Goossens, G. H. et al. 2011. “Increased Adipose Tissue Oxygen Tension in Obese Compared 
With Lean Men Is Accompanied by Insulin Resistance, Impaired Adipose Tissue 
Capillarization, and Inflammation.” Circulation 124(1):67–76. 
Goossens, Gijs H. and Ellen E. Blaak. 2015. “Adipose Tissue Dysfunction and Impaired 
Metabolic Health in Human Obesity: A Matter of Oxygen?” Frontiers in endocrinology 
6:55. 
Gorres, B. K., G. L. Bomhoff, A. A. Gupte, and P. C. Geiger. 2011. “Altered Estrogen Receptor 
Expression in Skeletal Muscle and Adipose Tissue of Female Rats Fed a High-Fat Diet.” 
Journal of Applied Physiology 110(4):1046–53. 
Grosfeld, Alexandra et al. 2002. “Hypoxia-Inducible Factor 1 Transactivates the Human Leptin 
Gene Promoter.” Journal of Biological Chemistry 277(45):42953–57. 
Gustafsson, Thomas. 2011. “Vascular Remodelling in Human Skeletal Muscle.” Biochemical 
Society Transactions 39(6):1628–32. 
van Haare, Judith et al. 2015. “Early Impairment of Coronary Microvascular Perfusion Capacity 
in Rats on a High Fat Diet.” Cardiovascular diabetology 14:150. 
Haas, T. L. et al. 2000. “Matrix Metalloproteinase Activity Is Required for Activity-Induced 
Angiogenesis in Rat Skeletal Muscle.” American journal of physiology. Heart and 
circulatory physiology 279(4):H1540-7. 
Haas, Tara L. 2002. “Molecular Control of Capillary Growth in Skeletal Muscle.” Canadian 
Journal of Applied Physiology 27(5):491–515. 
Haas, Tara L. 2005. “Endothelial Cell Regulation of Matrix Metalloproteinases.” Canadian 
journal of physiology and pharmacology 83(1):1–7. 
Haas, Tara L. and Emmanuel Nwadozi. 2015. “Regulation of Skeletal Muscle Capillary Growth 
in Exercise and Disease.” Applied Physiology, Nutrition, and Metabolism 40(12):1221–32. 
Halberg, N. et al. 2009. “Hypoxia-Inducible Factor 1  Induces Fibrosis and Insulin Resistance in 
White Adipose Tissue.” Molecular and Cellular Biology 29(16):4467–83. 
Harris, M.Brennan et al. 2001. “Reciprocal Phosphorylation and Regulation of Endothelial 
Nitric-Oxide Synthase in Response to Bradykinin Stimulation.” Journal of Biological 
Chemistry 276(19):16587–91. 
Haynes, M. P. et al. 2000. “Membrane Estrogen Receptor Engagement Activates Endothelial 
Nitric Oxide Synthase via the PI3-Kinase-Akt Pathway in Human Endothelial Cells.” 
Circulation research 87(8):677–82. 
Hedman, A., P. E. Andersson, R. Reneland, and H. O. Lithell. 2001. “Insulin-Mediated Changes 
in Leg Blood Flow Are Coupled to Capillary Density in Skeletal Muscle in Healthy 70-
Year-Old Men.” Metabolism: clinical and experimental 50(9):1078–82. 
van der Heijden, Roel A. et al. 2015. “High-Fat Diet Induced Obesity Primes Inflammation in 
Adipose Tissue prior to Liver in C57BL/6j Mice.” Aging 7(4):256–68. 
Hickey, M. S. et al. 1996. “Gender Differences in Serum Leptin Levels in Humans.” 
 77 
Biochemical and molecular medicine 59(1):1–6. 
Hishikawa, Keiichi et al. 1995. “Up-Regulation of Nitric Oxide Synthase by Estradiol in Human 
Aorticendothelial Cells.” FEBS Letters 360(3):291–93. 
Hong, Jina, Renee E. Stubbins, Rebekah R. Smith, Alison E. Harvey, and Nomelí P. Núñez. 
2009a. “Differential Susceptibility to Obesity between Male, Female and Ovariectomized 
Female Mice.” Nutrition Journal 8(1):11. 
Hong, Jina, Renee E. Stubbins, Rebekah R. Smith, Alison E. Harvey, and Nomelí P. Núñez. 
2009b. “Differential Susceptibility to Obesity between Male, Female and Ovariectomized 
Female Mice.” Nutrition journal 8:11. 
Hosogai, N. et al. 2007. “Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine 
Dysregulation.” Diabetes 56(4):901–11. 
Hsuchou, Hung et al. 2013. “Endothelial Cell Leptin Receptor Mutant Mice Have 
Hyperleptinemia and Reduced Tissue Uptake.” Journal of cellular physiology 228(7):1610–
16. 
Hu, Jing, Daryl J. Discher, Nanette H. Bishopric, and Keith A. Webster. 1998. “Hypoxia 
Regulates Expression of the Endothelin-1 Gene through a Proximal Hypoxia-Inducible 
Factor-1 Binding Site on the Antisense Strand.” Biochemical and Biophysical Research 
Communications 245(3):894–99. 
Inoue, Mayumi et al. 2013. “Thrombospondin 1 Mediates High-Fat Diet-Induced Muscle 
Fibrosis and Insulin Resistance in Male Mice.” Endocrinology 154(12):4548–59. 
Iruela-Arispe, M.Luisa, Michele Lombardo, Henry C. Krutzsch, Jack Lawler, and David D. 
Roberts. 1999. “Inhibition of Angiogenesis by Thrombospondin-1 Is Mediated by 2 
Independent Regions Within the Type 1 Repeats.” Circulation 100(13). 
Ishiki, Manabu and Amira Klip. 2005. “Minireview: Recent Developments in the Regulation of 
Glucose Transporter-4 Traffic: New Signals, Locations, and Partners.” Endocrinology 
146(12):5071–78. 
Jiménez, Benilde et al. 2000. “Signals Leading to Apoptosis-Dependent Inhibition of 
Neovascularization by Thrombospondin-1.” Nature Medicine 6(1):41–48. 
Jocken, Johan W. E. et al. 2007. “Adipose Triglyceride Lipase and Hormone-Sensitive Lipase 
Protein Expression Is Decreased in the Obese Insulin-Resistant State.” The Journal of 
Clinical Endocrinology & Metabolism 92(6):2292–99. 
Jocken, Johan W. E. and Ellen E. Blaak. 2008. “Catecholamine-Induced Lipolysis in Adipose 
Tissue and Skeletal Muscle in Obesity.” Physiology & Behavior 94(2):219–30. 
Kahn, C. R. and M. F. White. 1988. “The Insulin Receptor and the Molecular Mechanism of 
Insulin Action.” The Journal of clinical investigation 82(4):1151–56. 
Kanter, R. and B. Caballero. 2012. “Global Gender Disparities in Obesity: A Review.” Advances 
in Nutrition: An International Review Journal 3(4):491–98. 
Kaplan, Norman M. 1989. “The Deadly Quartet.” Archives of Internal Medicine 149(7):1514. 
Kim, Francis et al. 2008. “Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide 
Production Precede the Onset of Peripheral Insulin Resistance.” Arteriosclerosis, 
Thrombosis, and Vascular Biology 28(11). 
Kivela, R. et al. 2006. “Effects of Experimental Type 1 Diabetes and Exercise Training on 
Angiogenic Gene Expression and Capillarization in Skeletal Muscle.” The FASEB Journal 
20(9):1570–72. 
Kondo, Hiroyo et al. 2011. “Regressed Three-Dimensional Capillary Network and Inhibited 
Angiogenic Factors in the Soleus Muscle of Non-Obese Rats with Type 2 Diabetes.” 
 78 
Nutrition & Metabolism 8(1):77. 
Korshunov, Vyacheslav A., Stephen M. Schwartz, and Bradford C. Berk. 2007. “Vascular 
Remodeling: Hemodynamic and Biochemical Mechanisms Underlying Glagov’s 
Phenomenon.” Arteriosclerosis, thrombosis, and vascular biology 27(8):1722–28. 
Kotani, K. et al. 1994. “Sexual Dimorphism of Age-Related Changes in Whole-Body Fat 
Distribution in the Obese.” International journal of obesity and related metabolic 
disorders : journal of the International Association for the Study of Obesity 18(4):207–2. 
Kraegen, E. W. et al. 1993. “Glucose Transporters and in Vivo Glucose Uptake in Skeletal and 
Cardiac Muscle: Fasting, Insulin Stimulation and Immunoisolation Studies of GLUT1 and 
GLUT4.” The Biochemical journal (Pt 1):287–93. 
Krogh, A. 1919. “The Supply of Oxygen to the Tissues and the Regulation of the Capillary 
Circulation.” The Journal of physiology 52(6):457–74. 
Krotkiewski, M., P. Björntorp, L. Sjöström, and U. Smith. 1983. “Impact of Obesity on 
Metabolism in Men and Women. Importance of Regional Adipose Tissue Distribution.” The 
Journal of clinical investigation 72(3):1150–62. 
Kubis, Nathalie et al. 2002. “Decreased Arteriolar Density in Endothelial Nitric Oxide Synthase 
Knockout Mice Is due to Hypertension, Not to the Constitutive Defect in Endothelial Nitric 
Oxide Synthase Enzyme.” Journal of hypertension 20(2):273–80. 
Kubota, Naoto et al. 2002. “Disruption of Adiponectin Causes Insulin Resistance and Neointimal 
Formation.” Journal of Biological Chemistry 277(29):25863–66. 
Kupriyanova, T. A. and K. V Kandror. 1999. “Akt-2 Binds to Glut4-Containing Vesicles and 
Phosphorylates Their Component Proteins in Response to Insulin.” The Journal of 
biological chemistry 274(3):1458–64. 
Kurtovic, Silvia et al. 2015. “Leptin Enhances Endothelial Cell Differentiation and Angiogenesis 
in Murine Embryonic Stem Cells.” Microvascular Research 97:65–74. 
Kusters, Yvo H. A. M. and Eugene J. Barrett. 2016. “Muscle Microvasculature’s Structural and 
Functional Specializations Facilitate Muscle Metabolism.” American Journal of Physiology 
- Endocrinology And Metabolism 310(6):E379–87. 
Kwon, Hyokjoon and Jeffrey E. Pessin. 2013. “Adipokines Mediate Inflammation and Insulin 
Resistance.” Frontiers in endocrinology 4:71. 
Lafontan, M. et al. 1997. “Adrenergic Regulation of Adipocyte Metabolism.” Human 
reproduction (Oxford, England) 12 Suppl 1:6–20. 
Langberg, H., C. Bjørn, R. Boushel, Y. Hellsten, and M. Kjaer. 2002. “Exercise-Induced 
Increase in Interstitial Bradykinin and Adenosine Concentrations in Skeletal Muscle and 
Peritendinous Tissue in Humans.” The Journal of physiology 542(Pt 3):977–83. 
Ledoux, Séverine et al. 2008. “Angiogenesis Associated with Visceral and Subcutaneous 
Adipose Tissue in Severe Human Obesity.” Diabetes 57(12):3247–57. 
Lee, Warren L. and Amira Klip. 2016. “Endothelial Transcytosis of Insulin: Does It Contribute 
to Insulin Resistance?” Physiology 31(5). 
Leto, Dara and Alan R. Saltiel. 2012. “Regulation of Glucose Transport by Insulin: Traffic 
Control of GLUT4.” Nature Reviews Molecular Cell Biology 13(6):383–96. 
Li, Yongjun et al. 2007. “In Mice With Type 2 Diabetes, a Vascular Endothelial Growth Factor 
(VEGF)-Activating Transcription Factor Modulates VEGF Signaling and Induces 
Therapeutic Angiogenesis After Hindlimb Ischemia.” Diabetes 56(3). 
Liang, Jichao, Fengmei Han, and Yong Chen. 2013. “Transcriptional Regulation of VEGF 
Expression by Estrogen-Related Receptor ?” Acta Pharmaceutica Sinica B 3(6):373–80. 
 79 
Liao, James K. et al. 2000. “Interaction of Oestrogen Receptor with the Regulatory Subunit of 
Phosphatidylinositol-3-OH Kinase.” Nature 407(6803):538–41. 
Lihn, A. S., S. B. Pedersen, and B. Richelsen. 2005. “Adiponectin: Action, Regulation and 
Association to Insulin Sensitivity.” Obesity Reviews 6(1):13–21. 
Lillioja, Stephen et al. n.d. “Skeletal Muscle Capillary Density and Fiber Type Are Possible 
Determinants of In Vivo Insulin Resistance in Man.” 
Lindahl, P., M. Hellström, M. Kalén, and C. Betsholtz. 1998. “Endothelial-Perivascular Cell 
Signaling in Vascular Development: Lessons from Knockout Mice.” Current opinion in 
lipidology 9(5):407–11. 
Link, Jenny C., Xuqi Chen, Arthur P. Arnold, and Karen Reue. 2013. “Metabolic Impact of Sex 
Chromosomes.” Adipocyte 2(2):74–79. 
Liu, Jianguo et al. 2002. “Effects of Sex Hormones and Their Balance on the Proliferation of Rat 
Vascular Endothelial Cells.” Hormone research 58(1):16–20. 
Liu, Victor W. T. and Paul L. Huang. 2008. “Cardiovascular Roles of Nitric Oxide: A Review of 
Insights from Nitric Oxide Synthase Gene Disrupted Mice.” Cardiovascular research 
77(1):19–29. 
Lladó, Isabel et al. 2002. “Gender Effects on Adrenergic Receptor Expression and Lipolysis in 
White Adipose Tissue of Rats.” Obesity Research 10(4):296–305. 
Lolmède, K., V. Durand de Saint Front, J. Galitzky, M. Lafontan, and A. Bouloumié. 2003. 
“Effects of Hypoxia on the Expression of Proangiogenic Factors in Differentiated 3T3-
F442A Adipocytes.” International Journal of Obesity 27(10):1187–95. 
Lönnqvist, F., A. Thörne, V. Large, and P. Arner. 1997. “Sex Differences in Visceral Fat 
Lipolysis and Metabolic Complications of Obesity.” Arteriosclerosis, thrombosis, and 
vascular biology 17(7):1472–80. 
Lorenz, Mario et al. 2015. “Does Cellular Sex Matter? Dimorphic Transcriptional Differences 
between Female and Male Endothelial Cells.” Atherosclerosis 240(1):61–72. 
Losordo, D. W. and J. M. Isner. 2001. “Estrogen and Angiogenesis : A Review.” 
Arteriosclerosis, Thrombosis, and Vascular Biology 21(1):6–12. 
Mack, Peter J. et al. 2009. “Biomechanical Regulation of Endothelium-Dependent Events 
Critical for Adaptive Remodeling.” The Journal of biological chemistry 284(13):8412–20. 
Maeda, Norikazu et al. 2002. “Diet-Induced Insulin Resistance in Mice Lacking 
adiponectin/ACRP30.” Nature Medicine 8(7):731–37. 
Maguire, Janet J., Christopher M. Johnson, James W. Mockridge, and Anthony P. Davenport. 
1997. “Endothelin Converting Enzyme (ECE) Activity in Human Vascular Smooth 
Muscle.” British Journal of Pharmacology 122(8):1647–54. 
Maharaj, Arindel S. R., Magali Saint-Geniez, Angel E. Maldonado, and Patricia A. D’Amore. 
2006. “Vascular Endothelial Growth Factor Localization in the Adult.” The American 
Journal of Pathology 168(2):639–48. 
Malek, Moh H. and I.Mark Olfert. 2009. “Global Deletion of Thrombospondin-1 Increases 
Cardiac and Skeletal Muscle Capillarity and Exercise Capacity in Mice.” Experimental 
Physiology 94(6):749–60. 
Mancuso, Peter. 2016. “The Role of Adipokines in Chronic Inflammation.” ImmunoTargets and 
therapy 5:47–56. 
Margetic, S., C. Gazzola, G. G. Pegg, and R. A. Hill. 2002. “Leptin: A Review of Its Peripheral 
Actions and Interactions.” International Journal of Obesity 26(11):1407–33. 
Margosio, Barbara et al. 2008. “Fibroblast Growth Factor-2 Binding to the Thrombospondin-1 
 80 
Type III Repeats, a Novel Antiangiogenic Domain.” The international journal of 
biochemistry & cell biology 40(4):700–709. 
Mark, Allyn L., Marcelo L. G. Correia, Kamal Rahmouni, and William G. Haynes. 2002. 
“Selective Leptin Resistance: A New Concept in Leptin Physiology with Cardiovascular 
Implications.” Journal of hypertension 20(7):1245–50. 
Martyn, J. A.Jeevendra, Masao Kaneki, and Shingo Yasuhara. 2008. “Obesity-Induced Insulin 
Resistance and Hyperglycemia.” Anesthesiology 109(1):137–48. 
Mauvais-Jarvis, Franck, Deborah J. Clegg, and Andrea L. Hevener. 2013. “The Role of 
Estrogens in Control of Energy Balance and Glucose Homeostasis.” Endocrine reviews 
34(3):309–38. 
Medrikova, D. et al. 2012. “Sex Differences during the Course of Diet-Induced Obesity in Mice: 
Adipose Tissue Expandability and Glycemic Control.” International Journal of Obesity 
36(2):262–72. 
Mentzer, Steven J. and Moritz A. Konerding. 2014. “Intussusceptive Angiogenesis: Expansion 
and Remodeling of Microvascular Networks.” Angiogenesis 17(3):499–509. 
Messinis, I. E. et al. 1999. “Leptin Concentrations in Normal Women Following Bilateral 
Ovariectomy.” Human Reproduction 14(4):913–18. 
Michailidou, Zoi et al. 2012. “Increased Angiogenesis Protects against Adipose Hypoxia and 
Fibrosis in Metabolic Disease-Resistant 11β-Hydroxysteroid Dehydrogenase Type 1 
(HSD1)-Deficient Mice.” The Journal of biological chemistry 287(6):4188–97. 
Milkiewicz, M., M. D. Brown, S. Egginton, and O. Hudlicka. 2001. “Association between Shear 
Stress, Angiogenesis, and VEGF in Skeletal Muscles in Vivo.” Microcirculation (New 
York, N.Y. : 1994) 8(4):229–41. 
Milkiewicz, Malgorzata et al. 2007. “HIF-1alpha and HIF-2alpha Play a Central Role in Stretch-
Induced but Not Shear-Stress-Induced Angiogenesis in Rat Skeletal Muscle.” The Journal 
of physiology 583(Pt 2):753–66. 
Milkiewicz, Malgorzata et al. 2011. “Identification of a Mechanism Underlying Regulation of 
the Anti-Angiogenic Forkhead Transcription Factor FoxO1 in Cultured Endothelial Cells 
and Ischemic Muscle.” The American Journal of Pathology 178(2):935–44. 
Minokoshi, Yasuhiko et al. 2002. “Leptin Stimulates Fatty-Acid Oxidation by Activating AMP-
Activated Protein Kinase.” Nature 415(6869):339–43. 
Mitsumata, M., R. S. Fishel, R. M. Nerem, R. W. Alexander, and B. C. Berk. 1993. “Fluid Shear 
Stress Stimulates Platelet-Derived Growth Factor Expression in Endothelial Cells.” The 
American journal of physiology 265(1 Pt 2):H3-8. 
Montague, Carl T., Johannes B. Prins, Louise Sanders, Janet E. Digby, and Stephen O’Rahilly. 
1997. “Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: 
Implications for the Control of Regional Fat Distribution.” Diabetes 46(3). 
Moraes, R. C. et al. 2003. “Study of the Alteration of Gene Expression in Adipose Tissue of 
Diet-Induced Obese Mice by Microarray and Reverse Transcription-Polymerase Chain 
Reaction Analyses.” Endocrinology 144(11):4773–82. 
Mosher, D. F., M. J. Doyle, and E. A. Jaffe. 1982. “Synthesis and Secretion of Thrombospondin 
by Cultured Human Endothelial Cells.” The Journal of cell biology 93(2):343–48. 
Mulder, Hindrik et al. 2003. “Hormone-Sensitive Lipase Null Mice Exhibit Signs of Impaired 
Insulin Sensitivity Whereas Insulin Secretion Is Intact.” The Journal of biological chemistry 
278(38):36380–88. 
Muniyappa, Ranganath and Michael J. Quon. 2007. “Insulin Action and Insulin Resistance in 
 81 
Vascular Endothelium.” Current Opinion in Clinical Nutrition and Metabolic Care 
10(4):523–30. 
Murray, B. and D. J. Wilson. 2001. “A Study of Metabolites as Intermediate Effectors in 
Angiogenesis.” Angiogenesis 4(1):71–77. 
Nagy, K., J. Levy, and G. Grunberger. 1990. “High-Fat Feeding Induces Tissue-Specific 
Alteration in Proportion of Activated Insulin Receptors in Rats.” Acta endocrinologica 
122(3):361–68. 
Natali, Andrea et al. 2006. “Clustering of Insulin Resistance With Vascular Dysfunction and 
Low-Grade Inflammation in Type 2 Diabetes.” Diabetes 55(4). 
Neto-Ferreira, Rodrigo et al. 2014. “Metabolic Syndrome: From Human Organ Disease to Fetal 
Programming.” Journal of Metabolic Syndrome 3(1):1–10. 
Neufeld, Gera et al. 1996. “Similarities and Differences between the Vascular Endothelial 
Growth Factor (VEGF) Splice Variants.” Cancer and Metastasts Revtews 15(9):153–58. 
Newsholme, E. and G. Dimitriadis. 2001. “Integration of Biochemical and Physiologic Effects of 
Insulin on Glucose Metabolism.” Experimental and Clinical Endocrinology & Diabetes 
109(Suppl 2):S122–34. 
Nickelson, Karen J. et al. 2012. “A Comparison of Inflammatory and Oxidative Stress Markers 
in Adipose Tissue from Weight-Matched Obese Male and Female Mice.” Experimental 
diabetes research 2012:859395. 
Nwadozi, E. et al. 2016. “Endothelial FoxO Proteins Impair Insulin Sensitivity and Restrain 
Muscle Angiogenesis in Response to a High-Fat Diet.” The FASEB Journal 30(9):3039–52. 
O’Carroll, Anne-Marie, Stephen J. Lolait, Louise E. Harris, and George R. Pope. 2013. “The 
Apelin Receptor APJ: Journey from an Orphan to a Multifaceted Regulator of 
Homeostasis.” The Journal of endocrinology 219(1):R13-35. 
van den Oever, Inge A. M., Hennie G. Raterman, Mike T. Nurmohamed, and Suat Simsek. 2010. 
“Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus.” Mediators of 
inflammation 2010:792393. 
Olfert, I.Mark, Oliver Baum, Ylva Hellsten, and Stuart Egginton. 2016. “Advances and 
Challenges in Skeletal Muscle Angiogenesis.” American journal of physiology. Heart and 
circulatory physiology 310(3):H326-36. 
Olfert, I.Mark and Olivier Birot. 2011. “Importance of Anti-Angiogenic Factors in the 
Regulation of Skeletal Muscle Angiogenesis.” Microcirculation (New York, N.Y. : 1994) 
18(4):316–30. 
Ouchi, N. et al. 2003. “Association of Hypoadiponectinemia With Impaired Vasoreactivity.” 
Hypertension 42(3):231–34. 
Ouchi, Noriyuki et al. 2004. “Adiponectin Stimulates Angiogenesis by Promoting Cross-Talk 
between AMP-Activated Protein Kinase and Akt Signaling in Endothelial Cells.” The 
Journal of biological chemistry 279(2):1304–9. 
Ouchi, Noriyuki, Jennifer L. Parker, Jesse J. Lugus, and Kenneth Walsh. 2011. “Adipokines in 
Inflammation and Metabolic Disease.” Nature reviews. Immunology 11(2):85–97. 
Oviedo, Pilar J. et al. 2011. “Estradiol Induces Endothelial Cell Migration and Proliferation 
through Estrogen Receptor-Enhanced RhoA/ROCK Pathway.” Molecular and Cellular 
Endocrinology 335(2):96–103. 
Palmer, Biff F. and Deborah J. Clegg. 2015. “The Sexual Dimorphism of Obesity.” Molecular 
and cellular endocrinology 402:113–19. 
Pan, D. A. et al. 1997. “Skeletal Muscle Triglyceride Levels Are Inversely Related to Insulin 
 82 
Action.” Diabetes 46(6):983–88. 
Papapetropoulos, A., G. Garc?a-Carde?a, J. A. Madri, and W. C. Sessa. 1997. “Nitric Oxide 
Production Contributes to the Angiogenic Properties of Vascular Endothelial Growth Factor 
in Human Endothelial Cells.” Journal of Clinical Investigation 100(12):3131–39. 
Paranjape, S. G., A. V. Turankar, S. L. Wakode, and G. N. Dakhale. 2005. “Estrogen Protection 
against Coronary Heart Disease: Are the Relevant Effects of Estrogen Mediated through Its 
Effects on Uterus ? Such as the Induction of Menstruation, Increased Bleeding, and the 
Facilitation of Pregnancy?” Medical Hypotheses 65(4):725–27. 
Park, Hyun-Young et al. 2001. “Potential Role of Leptin in Angiogenesis: Leptin Induces 
Endothelial Cell Proliferation and Expression of Matrix Metalloproteinases in Vivo and in 
Vitro.” Experimental & Molecular Medicine 33(2):95–102. 
Pasarica, M. et al. 2008. “Reduced Adipose Tissue Oxygenation in Human Obesity: Evidence for 
Rarefaction, Macrophage Chemotaxis, and Inflammation Without an Angiogenic 
Response.” Diabetes 58(3):718–25. 
Pasarica, Magdalena et al. 2009. “Reduced Adipose Tissue Oxygenation in Human Obesity: 
Evidence for Rarefaction, Macrophage Chemotaxis, and Inflammation without an 
Angiogenic Response.” Diabetes 58(3):718–25. 
Pearson, Lachlan J., Timothy G. Yandle, M.Gary Nicholls, and John J. Evans. 2008. “Regulation 
of Endothelin-1 Release from Human Endothelial Cells by Sex Steroids and Angiotensin-
II.” Peptides 29(6):1057–61. 
Pepper, M. S. 1997. “Manipulating Angiogenesis. From Basic Science to the Bedside.” 
Arteriosclerosis, thrombosis, and vascular biology 17(4):605–19. 
Polderman, K. H. et al. 1993. “Influence of Sex Hormones on Plasma Endothelin Levels.” 
Annals of internal medicine 118(6):429–32. 
Power, Michael L. and Jay Schulkin. 2008. “Sex Differences in Fat Storage, Fat Metabolism, and 
the Health Risks from Obesity: Possible Evolutionary Origins.” British Journal of Nutrition 
99(5). 
Priego, Teresa, Juana Sánchez, Catalina Picó, and Andreu Palou. 2008. “Sex-Differential 
Expression of Metabolism-Related Genes in Response to a High-Fat Diet.” Obesity (Silver 
Spring, Md.) 16(4):819–26. 
Priego, Teresa, Juana Sánchez, Catalina Picó, and Andreu Palou. 2009. “Sex-Associated 
Differences in the Leptin and Ghrelin Systems Related with the Induction of Hyperphagia 
under High-Fat Diet Exposure in Rats.” Hormones and Behavior 55(1):33–40. 
Pries, A. R., T. W. Secomb, and P. Gaehtgens. 2000. “The Endothelial Surface Layer.” Pfl?gers 
Archiv - European Journal of Physiology 440(5):653–66. 
Prior, Steven J. et al. 2015. “Increased Skeletal Muscle Capillarization Independently Enhances 
Insulin Sensitivity in Older Adults After Exercise Training and Detraining.” Diabetes 
64(10):3386–95. 
Raitakari, M. et al. 1995. “Insulin Increases Blood Volume in Human Skeletal Muscle: Studies 
Using [15O]CO and Positron Emission Tomography.” The American journal of physiology 
269(6 Pt 1):E1000-5. 
Rask-Madsen, Christian and C.Ronald Kahn. 2012. “Tissue-Specific Insulin Signaling, 
Metabolic Syndrome, and Cardiovascular Disease.” Arteriosclerosis, thrombosis, and 
vascular biology 32(9):2052–59. 
Raugi, G. J., S. M. Mumby, D. Abbott-Brown, and P. Bornstein. 1982. “Thrombospondin: 
Synthesis and Secretion by Cells in Culture.” The Journal of cell biology 95(1):351–54. 
 83 
Rausch, M. E., S. Weisberg, P. Vardhana, and D. V Tortoriello. 2008. “Obesity in C57BL/6J 
Mice Is Characterized by Adipose Tissue Hypoxia and Cytotoxic T-Cell Infiltration.” 
International Journal of Obesity 32(3):451–63. 
Renna, Nicolás F., Natalia De Las Heras, and Roberto M. Miatello. 2013. “Pathophysiology of 
Vascular Remodeling in Hypertension.” International Journal of Hypertension 2013. 
Riant, Elodie, Haude Cogo, Jean-Franç Ois Arnal, Ré My Burcelin, and Pierre Gourdy. 2109. 
“Estrogens Protect against High-Fat Diet-Induced Insulin Resistance and Glucose 
Intolerance in Mice.” 
Rodriguez-Manzaneque, J. C. et al. 2001. “Thrombospondin-1 Suppresses Spontaneous Tumor 
Growth and Inhibits Activation of Matrix Metalloproteinase-9 and Mobilization of Vascular 
Endothelial Growth Factor.” Proceedings of the National Academy of Sciences 
98(22):12485–90. 
Rosen, Evan D. and Bruce M. Spiegelman. 2006. “Adipocytes as Regulators of Energy Balance 
and Glucose Homeostasis.” Nature 444(7121):847–53. 
Roudier, Emilie et al. 2009. “Angiomotin p80/p130 Ratio: A New Indicator of Exercise-Induced 
Angiogenic Activity in Skeletal Muscles from Obese and Non-Obese Rats?” The Journal of 
Physiology 587(16):4105–19. 
Rüegg, Joëlle et al. 2011. “Epigenetic Regulation of Glucose Transporter 4 by Estrogen Receptor 
β.” Molecular Endocrinology 25(12):2017–28. 
Rupnick, Maria A. et al. 2002. “Adipose Tissue Mass Can Be Regulated through the 
Vasculature.” Proceedings of the National Academy of Sciences of the United States of 
America 99(16):10730–35. 
Ryan, Alice S., Barbara J. Nicklas, and Dora M. Berman. 2002. “Hormone Replacement 
Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women.” Diabetes 
care 25(1):127–33. 
Saglam, Kenan. 2004. “Insulin Resistance and Postmenopausal Hormone Replacement 
Therapy.” Metabolic Syndrome and Related Disorders 2(4):234–40. 
Sakuma, I. et al. 1992. “NG-Methyl-L-Arginine, an Inhibitor of L-Arginine-Derived Nitric 
Oxide Synthesis, Stimulates Renal Sympathetic Nerve Activity in Vivo. A Role for Nitric 
Oxide in the Central Regulation of Sympathetic Tone?” Circulation Research 70(3). 
Scarpace, Philip J. and Yi Zhang. 2007. “Elevated Leptin: Consequence or Cause of Obesity?” 
Frontiers in bioscience : a journal and virtual library 12:3531–44. 
Schultz-Cherry, S. et al. 1995. “Regulation of Transforming Growth Factor-Beta Activation by 
Discrete Sequences of Thrombospondin 1.” The Journal of biological chemistry 
270(13):7304–10. 
Schwenk, Robert W., Graham P. Holloway, Joost J. F. P. Luiken, Arend Bonen, and Jan F. C. 
Glatz. 2010. “Fatty Acid Transport across the Cell Membrane: Regulation by Fatty Acid 
Transporters.” Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) 82(4–
6):149–54. 
Segal, Steven. 2005. “Regulation of Blood Flow in the Microcirculation.” Microcirculation 
12(1):33–45. 
Senthil Kumar, Shiva P. D. et al. 2014. “Distinct Metabolic Effects Following Short-Term 
Exposure of Different High-Fat Diets in Male and Female Mice.” Endocrine journal 
61(5):457–70. 
Shadid, S., C. Koutsari, and M. D. Jensen. 2007. “Direct Free Fatty Acid Uptake Into Human 
Adipocytes In Vivo: Relation to Body Fat Distribution.” Diabetes 56(5):1369–75. 
 84 
Shi, Haifei, Shiva Priya, and Dharshan Senthil. 2012. “Sex Differences in Obesity-Related 
Glucose Intolerance and Insulin Resistance.” Pp. 37–66 in Glucose Tolerance. 
Shimizu, H. et al. 1997. “Estrogen Increases in Vivo Leptin Production in Rats and Human 
Subjects.” The Journal of endocrinology 154(2):285–92. 
Shweiki, Dorit, Ahuva Itin, Dov Soffer, and Eli Keshet. 1992. “Vascular Endothelial Growth 
Factor Induced by Hypoxia May Mediate Hypoxia-Initiated Angiogenesis.” Nature 
359(6398):843–45. 
Sierra-Honigmann, M. R. et al. 1998. “Biological Action of Leptin as an Angiogenic Factor.” 
Science (New York, N.Y.) 281(5383):1683–86. 
Silvennoinen, Mika et al. 2013. “High-Fat Feeding Induces Angiogenesis in Skeletal Muscle and 
Activates Angiogenic Pathways in Capillaries.” Angiogenesis 16(2):297–307. 
Silverman, K. J. et al. 1988. “Angiogenic Activity of Adipose Tissue.” Biochemical and 
biophysical research communications 153(1):347–52. 
Solomon, Thomas P. J., Jacob M. Haus, Yanjun Li, and John P. Kirwan. 2011. “Progressive 
Hyperglycemia across the Glucose Tolerance Continuum in Older Obese Adults Is Related 
to Skeletal Muscle Capillarization and Nitric Oxide Bioavailability.” The Journal of 
Clinical Endocrinology & Metabolism 96(5):1377–84. 
Song, Ruo H., Hrachya K. Kocharyan, John E. Fortunato, Seymour Glagov, and Hisham S. 
Bassiouny. 2000. “Increased Flow and Shear Stress Enhance In Vivo Transforming Growth 
Factor-β1 After Experimental Arterial Injury.” Arteriosclerosis, Thrombosis, and Vascular 
Biology 20(4). 
Spencer, Michael et al. 2011. “Adipose Tissue Extracellular Matrix and Vascular Abnormalities 
in Obesity and Insulin Resistance.” The Journal of Clinical Endocrinology & Metabolism 
96(12):E1990–98. 
Steinberg, H. and A. Baron. 2002. “Vascular Function, Insulin Resistance and Fatty Acids.” 
Diabetologia 45(5):623–34. 
Strehlow, Kerstin et al. 2003. “Estrogen Increases Bone Marrow–Derived Endothelial Progenitor 
Cell Production and Diminishes Neointima Formation.” Circulation 107(24). 
Stubbins, Renee E., Valerie B. Holcomb, Jina Hong, and Nomelí P. Núñez. 2012. “Estrogen 
Modulates Abdominal Adiposity and Protects Female Mice from Obesity and Impaired 
Glucose Tolerance.” European Journal of Nutrition 51(7):861–70. 
Stubbins, Renee E., Valerie B. Holcomb, Jina Hong, and Nomelí P. Núñez. 2012. “Estrogen 
Modulates Abdominal Adiposity and Protects Female Mice from Obesity and Impaired 
Glucose Tolerance.” European journal of nutrition 51(7):861–70. 
Stump, Craig S., Erik J. Henriksen, Yongzhong Wei, and James R. Sowers. 2006a. “The 
Metabolic Syndrome: Role of Skeletal Muscle Metabolism.” Annals of Medicine 
38(6):389–402. 
Stump, Craig S., Erik J. Henriksen, Yongzhong Wei, and James R. Sowers. 2006b. “The 
Metabolic Syndrome: Role of Skeletal Muscle Metabolism.” Annals of Medicine 
38(6):389–402. 
Suganami, Eri et al. 2004. “Leptin Stimulates Ischemia-Induced Retinal Neovascularization: 
Possible Role of Vascular Endothelial Growth Factor Expressed in Retinal Endothelial 
Cells.” Diabetes 53(9):2443–48. 
Sun, Kai, Christine M. Kusminski, and Philipp E. Scherer. 2011. “Adipose Tissue Remodeling 
and Obesity.” The Journal of clinical investigation 121(6):2094–2101. 
Sung, Hoon-Ki et al. 2013. “Adipose Vascular Endothelial Growth Factor Regulates Metabolic 
 85 
Homeostasis through Angiogenesis.” Cell Metabolism 17(1):61–72. 
Taddei, S. and P. M. Vanhoutte. 1993. “Endothelium-Dependent Contractions to Endothelin in 
the Rat Aorta Are Mediated by Thromboxane A2.” Journal of cardiovascular 
pharmacology 22 Suppl 8:S328-31. 
Takahashi, Masafumi, Takafumi Ishida, Oren Traub, Marshall A. Coron, and Bradford C. Berk. 
1997. “Mechanotransduction in Endothelial Cells: Temporal Signaling Events in Response 
to Shear Stress.” Journal of Vascular Research 34(3):212–19. 
Taraboletti, G., D. Roberts, L. A. Liotta, and R. Giavazzi. 1990. “Platelet Thrombospondin 
Modulates Endothelial Cell Adhesion, Motility, and Growth: A Potential Angiogenesis 
Regulatory Factor.” The Journal of cell biology 111(2):765–72. 
Taylor, Lia E. and Jennifer C. Sullivan. 2016. “Sex Differences in Obesity-Induced Hypertension 
and Vascular Dysfunction: A Protective Role for Estrogen in Adipose Tissue 
Inflammation?” American Journal of Physiology - Regulatory, Integrative and Comparative 
Physiology 311(4). 
Terman, B. I. et al. 1992. “Identification of the KDR Tyrosine Kinase as a Receptor for Vascular 
Endothelial Cell Growth Factor.” Biochem Biophys Res Commun 187(3):1579–86. 
Tolsma, S. S. et al. 1993a. “Peptides Derived from Two Separate Domains of the Matrix Protein 
Thrombospondin-1 Have Anti-Angiogenic Activity.” The Journal of cell biology 
122(2):497–511. 
Tolsma, S. S. et al. 1993b. “Peptides Derived from Two Separate Domains of the Matrix Protein 
Thrombospondin-1 Have Anti-Angiogenic Activity.” The Journal of cell biology 
122(2):497–511. 
Tolsma, Sara S., M.Sharo. Stack, and No?l Bouck. 1997. “Lumen Formation and Other 
Angiogenic Activities of Cultured Capillary Endothelial Cells Are Inhibited by 
Thrombospondin-1.” Microvascular Research 54(1):13–26. 
Toth, M. J., A. Tchernof, C. K. Sites, and E. T. Poehlman. 2000. “Menopause-Related Changes 
in Body Fat Distribution.” Annals of the New York Academy of Sciences 904:502–6. 
Trayhurn, Paul and Suliman Yousef Alomar. 2015. “Oxygen Deprivation and the Cellular 
Response to Hypoxia in Adipocytes - Perspectives on White and Brown Adipose Tissues in 
Obesity.” Frontiers in endocrinology 6:19. 
Vincent, Michelle A. et al. 2004. “Microvascular Recruitment Is an Early Insulin Effect That 
Regulates Skeletal Muscle Glucose Uptake in Vivo.” Diabetes 53(6):1418–23. 
Voros, Gabor et al. 2005. “Modulation of Angiogenesis during Adipose Tissue Development in 
Murine Models of Obesity.” Endocrinology 146(10):4545–54. 
de Vries, C. et al. 1992. “The Fms-like Tyrosine Kinase, a Receptor for Vascular Endothelial 
Growth Factor.” Science (New York, N.Y.) 255(5047):989–91. 
Walshe, Tony E., Nathaniel G. dela Paz, and Patricia A. D’Amore. 2013. “The Role of Shear-
Induced Transforming Growth Factor-β Signaling in the Endothelium.” Arteriosclerosis, 
thrombosis, and vascular biology 33(11):2608–17. 
Wang, Shoujian, Zhifeng Wu, Christine M. Sorenson, Jack Lawler, and Nader Sheibani. 2003. 
“Thrombospondin-1-Deficient Mice Exhibit Increased Vascular Density during Retinal 
Vascular Development and Are Less Sensitive to Hyperoxia-Mediated Vessel Obliteration.” 
Developmental Dynamics 228(4):630–42. 
Weyer, Christian et al. 2001. “Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close 
Association with Insulin Resistance and Hyperinsulinemia.” The Journal of Clinical 
Endocrinology & Metabolism 86(5):1930–35. 
 86 
White, Amanda T. et al. 2014. “High-Fat Diet-Induced Impairment of Skeletal Muscle Insulin 
Sensitivity Is Not Prevented by SIRT1 Overexpression.” American Journal of Physiology - 
Endocrinology and Metabolism 307(9). 
WIEDEMAN, M. P. 1963. “Dimensions of Blood Vessels from Distributing Artery to Collecting 
Vein.” Circulation research 12:375–78. 
Williams, James L., David Cartland, John S. Rudge, and Stuart Egginton. 2006. “VEGF Trap 
Abolishes Shear Stress- and Overload-Dependent Angiogenesis in Skeletal Muscle.” 
Microcirculation (New York, N.Y. : 1994) 13(6):499–509. 
Wragg, Joseph W. et al. 2014. “Shear Stress Regulated Gene Expression and Angiogenesis in 
Vascular Endothelium.” Microcirculation 21(4):290–300. 
Xiang, Lusha, Jennifer Dearman, Sean R. Abram, Cory Carter, and Robert L. Hester. 2008. 
“Insulin Resistance and Impaired Functional Vasodilation in Obese Zucker Rats.” Am J 
Physiol Heart Circ Physiol 294:1658–66. 
Yadav, Amita, Megha A. Kataria, Vandana Saini, and Anil Yadav. 2013. “Role of Leptin and 
Adiponectin in Insulin Resistance.” Clinica Chimica Acta 417:80–84. 
Yanagisawa, Masashi et al. 1988. “A Novel Potent Vasoconstrictor Peptide Produced by 
Vascular Endothelial Cells.” Nature 332(6163):411–15. 
Yoneda, N. et al. 1998. “The Influence of Ovariectomy on Ob Gene Expression in Rats.” 
Hormone and Metabolic Research 30(5):263–65. 
Zeiher, Andreas M. et al. 1999. “Activation of Nitric Oxide Synthase in Endothelial Cells by 
Akt-Dependent Phosphorylation.” Nature 399(6736):601–5. 
Zhao, Xiaohui et al. 2008. “Estrogen Induces Endothelial Progenitor Cells Proliferation and 
Migration by Estrogen Receptors and PI3K-Dependent Pathways.” Microvascular Research 
75(1):45–52. 
Zhou, A., S. Egginton, O. Hudlická, and M. D. Brown. 1998. “Internal Division of Capillaries in 
Rat Skeletal Muscle in Response to Chronic Vasodilator Treatment with alpha1-Antagonist 
Prazosin.” Cell and tissue research 293(2):293–303. 
 
